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Chapter 1 
Introduction 
1.1 Chirality 
 
Figure 1.1. Drawing hands. Lithograph by MC Escher 1948. All M.C. Escher works © 2015 The M.C. Escher 
Company – the Netherlands. All rights reserved. Used by permission. www.mcescher.com (left) 
Shells of two different species of sea snail: the normally sinistral (left-handed) shell of Neptunea 
angulata, and the normally dextral (right-handed) shell of Neptunea despecta (right). 
 
Chirality describes a certain type of symmetry between objects. The word stems from 
the greek word Χειρ (kheir), which means hand. Hands are a good illustration of chirality. 
They are mirror images of each other but they are not identical or superimposable by rotation 
or translation (figure 1.1). The mirror image of an achiral object on the other hand leads to 
an identical object that is superimposable. Chirality occurs in all branches of science. In figure 
1.1 an example from Nature is shown: a sea snail that displays right- or left-handed shells, 
depending on the species it belongs to.   
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Molecules can be chiral as well. The most common example is a stereogenic carbon atom 
that has four different substituents, thereby forming a so-called stereocenter of a chiral 
molecule. Figure 1.2 shows the left and right handed version of the natural amino acid alanine. 
The mirror plane between them illustrates the mirror symmetry. Rotation of one of the 
molecules does not result in the other. For chiral molecules, the two mirror images are called 
enantiomers. Their physical properties like density, melting point, molecular weight etc. are 
identical, but they rotate polarized light in opposite directions by the same angle. 
 
Figure 1.2. Illustration of the mirror symmetry of (S)- and (R)-Alanine. The stereocenter is indicated with an 
asterisk.  
  
1.2 Properties of chiral molecules 
 
The circumstance that enantiomers have the same physical properties, except their 
interaction with polarized light, could lead to the assumption that chirality is an insignificant 
property. Chirality, however, is a very important topic for the reason that Nature has chosen 
to be homochiral. This means that amino acids in Nature have typically an (L) configuration 
and sugars typically a (D) configuration (for the various labels used see the nomenclature at 
the end of this chapter). Homochirality leads to chiral recognition, which results sometimes in 
fascinating effects. For example: the (S)-limonene enantiomer has a lemon-orange odor and 
the other has a piney, turpentine like odor. The (S)-asparagine molecule has a bitter taste 
whereas (R)-asparagine tastes sweet.1 Taste and smell are examples of the difference in 
molecular recognition by the receptors in the body when interacting with chiral molecules. 
The reason for this lies in the chiral nature of the receptors themselves.2 The fact that the 
body can differentiate between enantiomers due to its homochirality has sometimes more 
severe consequences. The laevorotatory base of epinephrine (adrenaline) is about 12 – 15 
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times as strong as the dextrorotatory form and for the isomeric isoadrenalines the 
laevorotatory is even 30 times as active on the blood pressure as its counterpart.3 In the case 
of the active pharmaceutical ingredient (API) thalidomide the (R)-enantiomer eased nausea 
in pregnant women whereas the (S) enantiomer was responsible for serious damage to the 
fetus.4 Consequently, API’s are often distributed as a pure enantiomer. Chiral purification 
became therefore an important step in the production of many active pharmaceutical 
ingredients.  
1.3 Chiral purification 
However, producing enantiomerically pure chemicals and API’s on an industrial scale is 
still challenging. There are several different possibilities to obtain pure compounds. One option 
is asymmetric synthesis, in which special chiral catalysts or solvents are used to direct the 
outcome. Although a very elegant way of obtaining enantiomerically pure compounds, the 
enantiomeric excess (ee) of the product does not always reach 100 %. In many cases, the 
two enantiomers are produced in equal amounts (i.e. as a racemic mixture) and then a chiral 
purification step is necessary. A powerful method to purify racemic mixtures of enantiomers 
is chiral preparative chromatography, mostly high-performance liquid chromatography 
(HPLC). Disadvantages, however, are the low throughput due to low column loadings and the 
large amount of solvent needed. Both methods, the asymmetric synthesis and the preparative 
HPLC are also rather expensive, which usually does not make them the first choice for the 
industry.  
An attractive method to purify compounds on an industrial scale is crystallization, a 
rather inexpensive method. One possibility is to convert the compound into a diastereomer by 
salt formation. Diastereomers have more than one stereocenter and are not mirror images of 
each other. Hence, they do have different physical properties, unlike enantiomers, resulting 
in different melting points and solubilities. Therefore, it is fairly unproblematic to separate 
diastereomers using crystallization.  
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Figure 1.3. Illustration of the different crystallization possibilities of intrinsically chiral compounds. An estimate of 
their respective abundance is given as a percentage.  
Some compounds crystallize as a racemic conglomerate thus form a mechanical mixture 
of enantiomerically pure crystals. The conglomerate crystal structure occurs only in roughly 
10 % of all intrinsically chiral organic compounds.5 Other compounds crystallize as a racemic 
compound and they are not suitable for chiral purification using crystallization (figure 1.3). 
The racemic conglomerates, though, can be purified immediately by means of crystallization. 
The most common method is preferential crystallization, also called entrainment. In this case 
the racemate is dissolved completely and just one of the enantiomers is crystallized. A seed 
crystal of the desired enantiomer is used to initiate the crystallization process. A crucial 
parameter for the reliability of this kind of purification is the metastable zone width (MZW). It 
describes the difference between the saturation temperature and the nucleation temperature 
of the compound. Designing a preferential crystallization process is labor-intensive, because 
prior information like the MZW or the solubility of the compound must be collected. Once the 
method is established the reproducibility can be quite high.6 The yield of preferential 
crystallization is relatively low, because the desired enantiomer is just 50 % of the racemate 
and there is also loss due to the solubility. Even more important is the fact that the 
crystallization has to be stopped before the counter enantiomer nucleates, which reduces the 
yield even more. The yield in preferential crystallization can be increased by conducting several 
runs with seed crystals alternating in handedness5 or by adding a racemization reaction.7  
  
Chapter 1 
5 
1.4 Viedma ripening 
 
Figure 1.4. Schematic representation of a Viedma ripening experiment. The magnetic stirrer (black) together with 
the glass beads lead to intense grinding of the crystals. The simultaneous attrition and growth of the 
crystals, together with a racemization reaction in the solution results in an autocatalytic process in 
which the solids end up in an enantiomerically pure state.  
A new and attractive alternative for purification of chiral compounds that involves 
racemization is Viedma ripening. In this case a racemic or scalemic mixture of crystals is 
vigorously ground, while in contact with its saturated solution in which a racemization reaction 
occurs (figure 1.4).8 The solid phase evolves to 100 % ee and the only loss is in most cases 
due to the solubility.9 Cristóbal Viedma conducted the first example of this method. He used 
sodium chlorate, which is an achiral molecule that crystallizes in a chiral space group (P213).8a 
The method was later adapted for intrinsically chiral molecules by Wim Noorduin et al. by 
using the Schiff base of a phenylglycine amide and introducing a racemization reaction in the 
solution.8b  
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Figure 1.5. Schematic illustration of the goal of the thesis. Starting point is a racemic compound, which does not 
allow successful Viedma ripening. By adding an achiral co-former or salt former the racemic 
compound is transformed into a racemic conglomerate co-crystal or salt. Viedma ripening should be 
feasible now. 
Viedma ripening is an elegant method that is very easy to conduct, but it has some 
prerequisites. The most important are that the compound must be a conglomerate and it must 
be racemisable in solution. These prerequisites are someties difficult to meet. In some cases, 
a racemization reaction is not possible or very harsh conditions are necessary. The 
requirement that the compound has to crystallize as a racemic conglomerate, however, is an 
even larger problem, because 90 % of the chiral molecules form racemic compounds and 
cannot be deracemized using normal Viedma ripening. The goal of this thesis is to find 
methods to enable Viedma ripening for this large class of materials. Figure 1.5 illustrates the 
basic idea behind this. 
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1.5 Outline 
 
In chapter 2 we demonstrate the deracemization of a metastable conglomerate. By 
tuning the process conditions, we avoid the formation of the stable racemic compound. One 
way to convert a racemic compound into a racemic conglomerate is by modifying it. 10 % of 
the chiral compounds form conglomerates, and thus with an average of 10 modifications a 
conglomerate will be found. Several types of modifications are possible, but in chapter 3 we 
demonstrate a very convenient one: salt formation. We also demonstrate the deracemization 
of these salts using temperature cycling (chapter 4). 
Under racemization conditions Asparagine forms a racemic compound and therefore 
racemization has to be avoided. We purified this compound by coupling two vessels of 
scalemic slurries. The crystal-free liquid is pumped around between the two vessels, providing 
a solution ee around 0 % and thus replacing the racemization reaction (chapter 5). N-
Acetylleucine is an example of a derivative that forms a stable conglomerate, but illustrates 
the problems that can arise while developing a Viedma ripening method (chapter 6).  
Several models have been presented that describe Viedma ripening, but none of these 
could explain the persistent reverse enantiomeric excess in solution, that was observed during 
the deracemization of the amino acid salts from chapter 3. In chapter 7 we therefore propose 
an extended model that includes thermally generated chiral nano clusters.  
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1.6 Nomenclature 
There are different ways to designate the two enantiomers. With respect to their optical 
activity and the direction in which the molecule rotates polarized light the labels (+) and (-) 
are used.  
The sign of the optical activity however, is not unambiguously related to the molecular 
structure. Therefore the D/L nomenclature uses glyceraldehyde as reference molecule. Drawn 
in the Fischer projection (figure 1.6), the OH group of the stereocenter is on the right side for 
the D (dexter; right) and on the left side for the L (laevus; left) molecule. The configuration 
of other molecules is compared to that of glyceraldehyde to determine whether they are D or 
L. 
 
Figure 1.6. Reference molecule glyceraldehyde for the D/L nomenclature in the Fischer projection.  
 
A more systematic way to designate a chiral molecule according to its configuration is 
the R/S nomenclature. It uses the Cahn-Ingold-Prelog (CIP) priority rules. The first step is to 
identify the stereocenter. The next step is to assign the priority to each substituent according 
to the atomic number. A higher atomic number means also a higher priority. When two 
identical atoms are bound to the stereocenter the atomic number of the atoms bound to them 
determine the priority (e.g. CH3 < CH2Cl). In the last step, the molecule is rotated such that 
the atom with the lowest priority is pointing away from the observer (figure 1.7). If the 
substituents are arranged clockwise from highest to lowest priority, the molecule is labeled 
(R) (rectus; right) the counterclockwise arrangement is labeled (S) (sinister; left).  
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Figure 1.7. Visualization of the CIP-priority rules and determination of the absolute configuration.  
The D/L and R/S nomenclature can be used simultaneously but do not necessarily lead 
to the same result. The alternative names for the proteinogenic amino acid cysteine in the 
different nomenclatures e.g. are (L)-cysteine and (R)-cysteine. The other proteinogenic (L)-
amino acids are all (S)-amino acids. 
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1.7 Molecular structures  
 
 
 
Figure 1.8. Molecular structures regarding chapter 2. 
 
 
Figure 1.9. Molecular structures regarding chapters 3, 4 and 7. 
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Figure 1.10. Molecular structures regarding chapter 5 (left) and chapter 6 (right). 
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Chapter 2 
Complete deracemisation of proteinogenic 
glutamic acid using Viedma ripening on a 
metastable conglomerate 
2.1 Abstract 
Viedma ripening is a process in which a compound that forms a stable racemic 
conglomerate can be converted to an enantiomerically pure solid state. Combining this 
deracemisation process with Ostwald’s rule of stages, allows Viedma ripening to be 
extended to a racemic compound for which the conglomerate exists only in a metastable 
form. This is demonstrated for glutamic acid, a proteinogenic amino acid. Since Ostwald 
ripening is one of the processes occurring during Viedma ripening, we thus make use of 
Ostwald twice.  
2.2 Introduction 
Several examples of complete deracemisation of chiral solids using abrasive grinding 
have been reported in recent years. The first experiment was that of Viedma on NaClO3, a 
compound that is achiral in solution.1 Inspired by Viedma’s result, Noorduin et al.2 successfully 
adapted the method for an intrinsically chiral amino acid derivative that undergoes base-
catalysed racemisation in solution. The method is now called Viedma ripening.3 In short, 
Viedma ripening involves the conversion of a racemic or scalemic mixture of a chiral compound 
into a single enantiomer by intense grinding of a slurry of the solids in a saturated solution, 
combined with a racemisation process in the solution. A prerequisite of the process is that the 
compound forms a racemic conglomerate i.e. separate left and right handed crystals.  
In previous work the possible relevance of Viedma ripening for the evolution of 
biomolecules to single handedness has been discussed.4-6 The first deracemisation of a 
proteinogenic amino acid exploited an artificial conglomerate of aspartic acid obtained by 
mixing R and S solids.7 This compound forms a racemic compound under normal 
circumstances.8-9 Only 3 of the 20 proteinogenic amino acids are reported to form a racemic 
conglomerate.9 Deracemisation of natural amino acids using grinding, therefore, is quite a 
challenge. On top of that, even the mildest conditions for the necessary racemisation still are  
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rather harsh (100 °C in acetic acid with salicylaldehyde).10 Here we report the complete 
deracemisation of a scalemic mixture of glutamic acid using Viedma ripening.  
Glutamic acid is one of the natural amino acids that is claimed to form a racemic 
conglomerate.9-11 It is the industrially most produced amino acid in the world12 and the most 
abundant chiral, proteinogenic amino acid present in the Murchison meteorite.13 It is 
remarkable that all the amino acids found in this meteorite show an excess in the S 
enantiomer. In the case of glutamic acid it is between 50 and 70 % ee depending on the 
extraction method.13 For glutamic acid the conglomerate is not the only possible crystal 
structure. Commercial (RS)-glutamic acid is a racemic hydrate.14-15 It exists also in the form 
of an anhydrous racemic compound.16 According to Menozzi11 recrystallisation from water is 
sufficient to get the glutamic acid conglomerate, but we could not reproduce this. After trying 
several recrystallisation methods from acid solvents, it turned out to be possible to obtain the 
conglomerate by grinding the racemic hydrate in acetic acid at elevated temperatures (40 – 
100 °C).  
 
 
scheme 2.1. Equilibria involved in the attrition-enhanced deracemisation of glutamic acid (Glu).  
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2.3 Experimental section 
For the deracemisation a suspension of glutamic acid (300 mg) with various initial 
enantiomeric excess (ee) values was stirred (260 rpm) in acetic acid (5 mL) at 70 °C in the 
presence of 2 mm glass beads (1.7 g). After the hydrate was converted into the conglomerate, 
as checked using X-ray powder diffraction (XRPD), the solution-phase racemisation was 
initiated by adding salicylaldehyde (70 mg) and increasing the temperature to 90 °C. Samples 
of the solids were collected over time and the enantiomeric purity was measured using two 
independent chiral HPLC methods. (see supporting information) 
 
2.4 Results and discussion 
We observed that the continuous attrition of the crystals with an initial ee combined with 
the racemisation in solution leads to a rise in ee in time. In contrast to the attrition enhanced 
deracemisation experiments of Noorduin et al., however, the pure enantiomeric state was not 
reached by just prolonging the duration of the experiment (not shown). The experimental 
conditions were therefore adapted, as described above, such as to obtain complete 
deracemisation within 24 h. This was achieved by working with a high starting ee, a rather 
large amount of glass beads and less glutamic acid to increase the deracemisation rate.17 The 
results for the R and S enantiomer are almost identical (Fig. 2.1a). The deracemisation curves 
show the tendency to sigmoidal shapes (Fig. 2.1a) as found in most of the experimental work1-
3, 5, 7, 17 and as explained in computer simulations of the process.18-21 Experiments with a low 
initial ee, however, showed a leveling off of the ee in time. (Fig. 2.1a)  
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Figure 2.1. Attrition-enhanced evolution of solid-phase ee for glutamic acid; (a) at 90 °C starting from initial ee 
values as shown. (b) deracemisation attempts at different temperatures all starting with ee = 64 %. 
Lines are a guide to the eye. 
Surprisingly, prolonging of the deracemisation leads to a decrease of the solid phase ee 
even after having reached 100 %. (Fig. 2.1b). Experiments which were conducted at lower 
temperature remained much longer at 100 % ee. (Fig. 2.1b) A possible explanation for this is 
that the racemic conglomerate is metastable and is converted into the stable anhydrous 
racemic compound, following Ostwald’s rule of stages.22 This leads to a decrease in ee as the 
racemic compound cannot be deracemised and the racemisation process will result in a zero 
ee in the end. In order to check this possibility, we examined the stability of the various crystal 
structures of glutamic acid using differential-scanning calorimetry (DSC) and XRPD (see 
supporting information). DSC indeed shows that the conglomerate is less stable than the 
anhydrous racemic compound, at least at temperatures near the melting point. XRPD confirms 
that under grinding conditions the racemic compound occurs after 20 hours. The transition is 
completed after approximately 48 hours. The hydrate is the least stable and does not play a 
role in the evolution of the solid phase ee. 
The relative stability at room temperature was determined by gently stirring of a mixture 
of crystals of two different glutamic acid structures in a saturated water or acetic acid solution. 
A mixture of the anhydrous racemic compound and the hydrate, which is also a racemic 
compound when stirred in water, evolved after two days into the pure anhydrous racemic 
compound, as shown using XRPD. A mixture of the conglomerate and the anhydrous racemic 
compound when stirred in acetic acid at room temperature, even after a week, still showed a 
mixture of these two compounds. Only after 30 days, it became apparent that the anhydrous 
racemic compound of glutamic acid is the stable one under these circumstances, although 
there were still traces of the conglomerate left. The conversion of the conglomerate into the 
racemic compound in acetic acid is enhanced at elevated temperatures. This was proven by 
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an experiment conducted at 40 °C in which the crystal structure was completely converted 
after 14 days. These results confirm the presumption that the conglomerate is kinetically 
formed according to Ostwald’s rule of stages. The successful deracemisation experiments were 
conducted at temperatures where the conglomerate survived long enough to reach 100 % ee, 
before significant formation of the racemic compound. 
The racemisation conditions for amino acids in acetic acid as solvent are typically 100 
°C using salicylaldehyde as a catalyst. Fig 2.1b shows that increasing the temperature leads 
to a faster deracemisation, probably partly due to a faster racemisation in the liquid. On the 
other hand, the high temperature experiments result in a faster conversion into the racemic 
compound. Another effect that might play a role in the temperature dependent behavior is 
the formation of pyroglutamic acid in the solution which exists only as a racemic compound 
and might act as a kind of catalyst for the formation of the glutamic acid racemic compound 
structure. To test this a Viedma ripening experiment was performed with and without 
pyroglutamic acid added at the start of the experiment. These experiments gave almost 
identical deracemisation curves, so we conclude that the effect of pyroglutamic acid can be 
neglected (see supporting information).  
The experiments conducted at a lower temperature were more time consuming. 
Nevertheless, they gave a better result in terms of the preservation of the conglomerate crystal 
structure. A complete deracemisation with an initial ee of 14 % was even possible. (Fig. 2.2a) 
Beginning at even lower initial ee’s displayed a definite increase in the solid phase ee. (Fig. 
2.2b) 
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Figure 2.2. Viedma ripening of glutamic acid at different temperatures and low starting ee’s. 
 
Partial dissolving of a chiral scalemic compound leads to a higher ee in the solid phase. 
The same can happen if the compound decomposes. To distinguish between a rising ee due 
to decomposition or to Viedma ripening the yield of the grinding experiment must be 
determined. For glutamic acid the yield is around 80 % (see supporting information). No 
decomposition takes place during this experiment. The loss is due to the solubility of glutamic 
acid in the solvent and the formation of a minor amount of pyroglutamic acid, mainly in the 
solution.  
We have thus found that the deracemisation of glutamic acid in acetic acid is affected 
by several processes (scheme 2.2). In the beginning it is, just as in the experiments conducted 
by Noorduin et al., the deracemisation rate constant is simply determined by the racemisation 
efficiency via the solution.17 During the course of the experiment the formation of the racemic 
compound poses the largest problem, while the formation of pyroglutamic acid also becomes 
an issue, especially at the highest temperatures leading to a lower yield. These simultaneous 
processes, which occur all at different rates, act in a delicate balance and might explain the 
absence of the typical sigmoidal curves. (Fig. 2.2a) The emergence of a solid phase with single 
chirality is therefore not guaranteed although still achievable by carefully tuning the conditions 
to minimize the side processes.  
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scheme 2.2. Compounds and crystal structures which participate in the deracemisation process. At high T 
deracemisation is hampered due to formation of racemic compounds. 
 
2.5 Conclusion 
We have demonstrated a Viedma ripening method for the proteinogenic amino acid 
glutamic acid at temperatures far below literature suggestions.7, 10 In the process, we make 
use of Ostwald twice. First of all Ostwald’s rule of stages22 leading to the kinetic formation of 
the required conglomerate and secondly Ostwald ripening which plays an important role in 
Viedma ripening.3, 23-24 It is the first example of a successful deracemisation experiment 
employing a metastable conglomerate. This expands the application of Viedma ripening to 
substances which form a kinetic conglomerate. 
 
2.6 References 
1. Viedma, C., Physical Review Letters 2005, 94 (6), 065504-+. 
2. Noorduin, W. L.; Izumi, T.; Millemaggi, A.; Leeman, M.; Meekes, H.; Van Enckevort, 
W. J. P.; Kellogg, R. M.; Kaptein, B.; Vlieg, E.; Blackmond, D. G., Journal of the 
American Chemical Society 2008, 130 (4), 1158-+. 
3. Noorduin, W. L.; van Enckevort, W. J. P.; Meekes, H.; Kaptein, B.; Kellogg, R. M.; 
Tully, J. C.; McBride, J. M.; Vlieg, E., Angewandte Chemie-International Edition 2010, 
49 (45), 8435-8438. 
4. Viedma, C., Astrobiology 2007, 7 (2), 312-319. 
5. Noorduin, W. L.; Bode, A. A. C.; van der Meijden, M.; Meekes, H.; van Etteger, A. F.; 
van Enckevort, W. J. P.; Christianen, P. C. M.; Kaptein, B.; Kellogg, R. M.; Rasing, T.; 
Vlieg, E., Nature Chemistry 2009, 1 (9), 729-732. 
Chapter 2 
19 
6. Crusats, J.; Veintemillas-Verdaguer, S.; Ribo, J. M., Chem.-Eur. J. 2006, 12 (30), 
7776-7781. 
7. Viedma, C.; Ortiz, J. E.; de Torres, T.; Izumi, T.; Blackmond, D. G., Journal of the 
American Chemical Society 2008, 130 (46), 15274-+. 
8. Flaig, R.; Koritsanszky, T.; Zobel, D.; Luger, P., Journal of the American Chemical 
Society 1998, 120 (10), 2227-2238. 
9. Jean Jacques, A. C., Samuel H. Wilen, Enantiomers, Racemates, and Resolutions. 
Krieger: Malabar, Florida, 1994. 
10. Yamada, S.; Hongo, C.; Yoshioka, R.; Chibata, I., J. Org. Chem. 1983, 48 (6), 843-
846. 
11. A. Menozzi, G. A., Chemisches Central-Blatt 1894, 65, 463-+. 
12. Izumi, Y.; Chibata, I.; Itoh, T., Angewandte Chemie-International Edition in English 
1978, 17 (3), 176-183. 
13. Engel, M. H.; Nagy, B., Nature 1982, 296 (5860), 837-840. 
14. Ciunik, Z.; Glowiak, T., Acta Crystallographica Section C-Crystal Structure 
Communications 1983, 39 (SEP), 1271-1273. 
15. Flaig, R.; Koritsanszky, T.; Dittrich, B.; Wagner, A.; Luger, P., Journal of the American 
Chemical Society 2002, 124 (13), 3407-3417. 
16. Dunitz, J. D.; Schweizer, W. B., Acta Crystallographica Section C-Crystal Structure 
Communications 1995, 51, 1377-1379. 
17. Noorduin, W. L.; Meekes, H.; van Enckevort, W. J. P.; Millemaggi, A.; Leeman, M.; 
Kaptein, B.; Kellogg, R. M.; Vlieg, E., Angewandte Chemie-International Edition 2008, 
47 (34), 6445-6447. 
18. Noorduin, W. L.; Meekes, H.; Bode, A. A. C.; van Enckevort, W. J. P.; Kaptein, B.; 
Kellogg, R. M.; Vlieg, E., Cryst. Growth Des. 2008, 8 (5), 1675-1681. 
19. Uwaha, M., J. Cryst. Growth 2011, 318 (1), 89-92. 
20. Saito, Y.; Hyuga, H., J. Cryst. Growth 2011, 318 (1), 93-98. 
21. Iggland, M.; Mazzotti, M., Cryst. Growth Des. 2011, 11 (10), 4611-4622. 
22. Ostwald, W., Zeitschrift für Physikalische Chemie 1897, 22, 289-+. 
23. Ostwald, W., Lehrbuch der Allgemeinen Chemie, Vol. 2, Part1: Leipzig, Germany, 1896. 
24. Liesegang, R. E. J., Zeitschrift für physikalische Chemie 1911, 75, 374. 
Formation of a salt enables complete deracemisation of a racemic compound through Viedma 
ripening 
 
20 
 
Chapter 3 
Formation of a salt enables complete 
deracemisation of a racemic compound 
through Viedma ripening 
 
 
3.1 Abstract 
Chiral purification is a very important step in the production of many products such as 
active pharmaceutical ingredients (API). These procedures are typically limited to a maximum 
yield of 50 %. Methods that include a racemisation method, like Viedma ripening, offer a 
theoretical yield of 100 %. Racemic conglomerate formation is a necessary condition for chiral 
purification processes that exploit crystallisation, like Viedma ripening. This condition forms a 
limiting factor because only 10 % of the chiral organic molecules crystallize in this way, the 
other 90 % form racemic compounds. For two compounds that crystallize as racemic 
compounds we demonstrate that salt formation can transform these into racemic 
conglomerates and show that these can subsequently be fully deracemized using Viedma 
ripening. Salt formation thus promises to be a crystal engineering tool to significantly extend 
the applicability of Viedma ripening.  
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3.2 Introduction 
A recent development in chiral purification is deracemisation using Viedma ripening. 
Viedma ripening is a process in which a racemic mixture of enantiomorphic crystals in contact 
with a saturated solution is strongly ground, resulting in single handedness of the solids.1 This 
was shown by Viedma in a seminal paper for the in solution achiral compound sodium chlorate 
(NaClO3), which crystallizes in a chiral spacegroup (P213). By adding a racemisation catalyst 
to the solution, Noorduin et al. extended the method to chiral molecules.2  
In order to conduct Viedma ripening on a chiral compound it has to meet two main 
requirements. Firstly, the compound should be racemizable in solution without forming a 
significant amount of side products. Secondly, the compound should crystallize as a racemic 
conglomerate. A conglomerate equates a mechanical mixture of crystals of the two pure 
enantiomers.3  
While finding racemizing conditions is not always possible, the second condition is even 
more restrictive because around 90 % of all organic chiral compounds crystallize as a racemic 
compound for which both enantiomers are present in the unit cell. The proteinogenic amino 
acids are a clear example of this. According to Jacques, Collet and Wilen only 3 of the 20 
proteinogenic amino acids crystallize as a conglomerate, namely asparagine monohydrate, 
threonine and glutamic acid.3 Asparagine monohydrate, however, is not stable under the 
racemisation conditions, while threonine has a second chiral center which cannot be racemised 
easily by the same method. For glutamic acid the stable form was recently found to be a 
racemic compound.4 Therefore, different routes have to be found for the proteinogenic amino 
acids as well as for other racemic compounds.  
One approach is to make derivatives of the compound such that it forms a racemic 
conglomerate. Noorduin et al., for example, used a Schiff base amide of phenylglycine, which 
forms a stable racemic conglomerate.2, 5 Recently we and our collaborators reported the 
complete deracemisation of glutamic acid by exploiting the relatively long life time of a 
metastable conglomerate phase under the deracemisation conditions.4a Both these methods 
have drawbacks, because chemically altering a compound may be time-consuming and 
attended by loss of material, while for most compounds a suitable metastable conglomerate 
will not be available. An attractive alternative that has not been tried so far is the use of a 
salt. Most chiral molecules that can form salts should be transformable into a conglomerate 
by finding an appropriate cation or anion. Here we demonstrate this concept by reporting the 
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deracemisation of a conglomerate forming salt for the proteinogenic amino acids alanine and 
phenylalanine.  
 
3.3 Results and discussion 
Deracemisation of amino acids requires a way to racemise these compounds in solution. 
Common methods involve the use of strong acids or bases or heating the amino acids in water 
in a sealed vessel at high temperatures (150 - 250 °C) and pressures, resulting in a racemate 
but also in decomposition.6 The mildest racemisation reaction for amino acids is conducted in 
acetic acid, at 100 °C using salicylaldehyde as a catalyst.7 The racemisation of amino acid 
salts is more difficult than of free amino acids, especially when the amino group is protonated. 
This prevents the formation of the required Schiff base for the racemisation reaction.7 
According to Hongo et al. this problem can be overcome by adding some free amino acid.8 
Free amino acids undergo the formation of a Schiff base more easily and are therefore 
racemisable. The racemisation rate is proportional to the amount of free amino acid. To get a 
sufficient racemisation rate, a molar ratio of the compounds (amino acid and salt) in the 
system is recommended such that 10 % comprises the free amino acid.8  
Next, an appropriate salt needs to be selected. Sulfonates are good candidates for the 
amino acids. First of all, they have a lower pKa as compared to acetic acid, so they will form 
a salt even with pure acetic acid as the solvent. Secondly, the large amount of different 
benzenesulfonic acid derivatives makes it likely to find a conglomerate-forming salt. In 
particular numerous amino acid benzenesulfonate conglomerates are reported in the 
literature. These are mostly crystallized from water and therefore some of them are hydrates, 
which will not be formed in the hygroscopic environment of pure acetic acid.9  
Two waterfree amino acid benzenesulfonate conglomerates were found in the literature: 
alanine 4-chlorobenzenesulfonate and serine 4-toluenesulfonate.9b The latter, however, 
although claimed to form a conglomerate, gives a racemic compound in acetic acid. Therefore 
a more systematic screening for conglomerate salts was performed using six amino acids and 
four sulfonates, see table 3.1. Both the racemic and enantiopure amino acids were suspended 
in acetic acid with one of four different benzenesulfonic acid derivatives. The solid phases 
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were analyzed using X-ray powder diffraction (XRPD). An identical XRPD pattern of the 
racemic and the enantiopure salt indicates the existence of a racemic conglomerate structure. 
 
Table 3.1. Results of conglomerate screening of amino acid sulfonates in acetic acid. 
 TSAa CBSa BSAa XSAa 
Alanine - + - - 
Leucine - - - + 
Phenylalanine - - - + 
Phenylglycine - - - - 
Serine - - - - 
Methionine - - - - 
a TSA = toluenesulfonic acid, CBS = 4-chlorobenzensulfonic acid, BSA = benzenesulfonic acid, XSA = 2,5-
xylenesulfonic acid, (-) = negative, (+) = positive result 
 
In addition to alanine 4-chlorobenzenesulfonate (Ala-CBS) mentioned above9b, two other 
conglomerates were found under these conditions: leucine-2,5-xylenesulfonate (Leu-XSA) and 
phenylalanine-2,5-xylenesulfonate (Phe-XSA). The other combinations failed to form 
conglomerate crystals and are not discussed further. So 3 out of 24, i.e. 13 %, investigated 
combinations form a racemic conglomerate which is in agreement with the common 
assumption that 10 % of all chiral organic compounds are conglomerates. Figure 3.1 shows 
the XRPD patterns of the RS and S compounds for Ala-CBS and Phe-XSA.  
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Figure 3.1. X-ray powder diffraction patterns (above) of the in situ produced (RS)-Ala-CBS compared with the 
XRPD calculated from (S)-Alanine 4-chlorobenzenesulfonate (CSD structure refcode KERMOJ) and 
(RS)- and (S)-Alanine. Below: the in situ produced (RS)-Phe-XSA compared to the XRPD calculated 
from the single crystal structure and (S)-Phe-XSA. This shows that (RS)-Ala-CBS and Phe-XSA 
indeed form racemic conglomerates, while the free amino acids form racemic compounds. 
 
The structures of (S)-Ala-CBS and (S)-Leu-XSA . 1 H2O were found in the Cambridge 
Structural Database (CSD) and the calculated XRPD’s were identical with the XRPD’s of the 
screening experiments (see supporting information and Figure 3.1). Unfortunately, hydrates, 
like Leu-XSA, do not show high stability in acetic acid at elevated temperatures. Therefore 
only Ala-CBS and Phe-XSA were used for further experiments. Phe-XSA crystals were grown 
from racemic phenylalanine and the structure was determined using single crystal X-ray 
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diffraction. The structure exhibits the typical double layers containing hydrophilic H-bonds and 
hydrophobic van der Waals interaction between the benzene rings (see Figure 3.2). Phe-XSA 
has a monoclinic spacegroup (C2, a =  21.6898(3)Å, b = 5.2152(9)Å, c = 18.2370(15)Å, β = 
125.000(6)°). 
 
Figure 3.2. Single crystal X-ray diffraction structure of phenylalanine-p-xylenesulfonate viewed along the b-axis. 
 
Ala-CBS crystals were grown from a racemic solution as well and they were investigated 
using single crystal X-ray diffraction. The determined spacegroup is P212121, which confirms 
that the racemate forms a conglomerate. As expected, the calculated XRPD from that structure 
closely resembles the KERMOJ and (RS)-Ala-CBS XRPD diagrams.  
In the case of Ala-CBS chiral HPLC measurements, however, determined selected crystals 
to be scalemic (enantiomeric excess varied between 3 % and 77 % (see supporting 
information)). This is explained by the formation of an epitaxial conglomerate, consisting of 
alternating layers of the different enantiomers.10 This results in racemic or scalemic crystals 
in an enantiomorphous space group. Proof of this is obtained by placing selected single 
crystals of Ala-CBS grown from racemic alanine under a polarization microscope in a slightly 
supersaturated solution of (S)-Ala-CBS.10a, 10c, 11 In the case of a pure (S)-Ala-CBS crystal, the 
only observation would be growth of the crystal. In case of a pure (R)-Ala-CBS crystal it would 
dissolve because the solution is undersaturated in (R)-Ala-CBS according to Meyerhoffer’s 
double solubility rule.12 In our crystals, some layers grow and others dissolve, showing that 
both (S) and (R) layers are present. (see Figure 3.3). Nevertheless, even for epitaxial 
conglomerates Viedma ripening is feasible.11 
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Figure 3.3. Dissolution / growth experiment of a single crystal grown from racemic Ala-CBS in a slightly 
supersaturated solution of (S)-Ala CBS. The dashed lines indicate fixed position of the crystal 
pictured at the top. It is clear that some layers grow, while others dissolve. 
 
As the next step, deracemisation experiments were conducted for alanine 4-
chlorobenzenesulfonic acid as well as for phenylalanine 2,5-xylenesulfonic acid. In all 
experiments an excess of amino acid is used to obtain 13 to 28 % free amino acid. Various 
fractions of pure enantiomer, depending on the desired initial enantiomeric excess (ee) were 
added. This mechanical mixture was ground in acetic acid in the presence of glass beads. The 
salts (Ala-CBS / Phe-XSA) were obtained by grinding the mixture for at least 30 minutes as 
was determined using X-ray powder diffraction (see Figure 3.1). The racemisation reaction 
was then started by adding salicylaldehyde. Samples were taken over time and analysed using 
chiral HPLC. See supporting information for further details. 
Figure 3.4 shows the results of some characteristic deracemisation experiments, all 
conducted at 70 °C with various initial ee. The solid phase ee always evolved to 100 %. The 
time needed for the deracemisation depends on the initial ee. 
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Figure 3.4. Evolution of the solid phase ee for Ala-CBS (above) and Phe-XSA (below) with different initial ee 
values as shown. All experiments were conducted at 70 °C. Lines are a guide to the eye. 
 
The curves show a clear sigmoidal shape, which is typical for Viedma ripening.1-2, 5a, 13 
The experiments result in a stable, enantiomerically pure end state apart from a few cases of 
Ala-CBS where the solid phase enantiomeric excess showed some fluctuations after having 
reached 100 % ee (see supporting information). 
The small amount of enantiomerically pure compound determines whether the final state 
is left or right handed depending on which enantiomer was used in excess. Racemically started 
experiments should give a statistical result, 50 % would yield left handed crystals, the other 
50 % right handed.1 Three experiments of Ala-CBS were conducted starting racemic, running 
for at least a week and all of them stayed racemic. In the case of Phe-XSA all 10 racemically 
started experiments resulted in a left handed final state. This phenomenon was observed also 
for other compounds and the reason is probably induced by minor chiral impurities in the 
starting substance.14 
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3.4 Conclusion 
Our results demonstrate that Viedma ripening is possible for a salt forming chiral 
molecule. The free amino acids can be regained by neutralizing with alkali or by use of an ion 
exchange resin.9a In these specific cases of alanine 4-chlorobenzenesulfonic acid and 
phenylalanine 2,5-xylenesulfonic acid, the deracemisation proceeds without side products, as 
confirmed by NMR and HPLC, in good yield and reasonable time. The process is not hindered 
by the fact that the Ala-CBS forms an epitaxial conglomerate.  
Alanine and Phenylalanine as a free amino acid form a racemic compound (figure 3.1) 
and are therefore not suited for Viedma ripening. The conversion of a racemic compound 
forming substance into a racemic conglomerate greatly expands the applicability of Viedma 
ripening. Salts are a particularly attractive option to transform a racemic compound into a 
conglomerate because of their wide scope and the fact that there is no need to chemically 
alter the chiral compound. Similar benefits apply to co-crystals in general (of which salts are 
a special case)15, offering an enormous number of candidates for Viedma ripening in crystal 
engineering.15-16  
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Chapter 4 
Deracemization of a racemic compound  
via its conglomerate-forming salt  
using temperature cycling 
4.1 Abstract 
Deracemization using programmed temperature cycles is restricted to chiral molecules 
which crystallize as a racemic conglomerate. We exemplify a strategy to loosen this restriction 
for the model compound Phenylalanine. Phenylalanine is a racemic compound that forms a 
conglomerate salt with 2,5-Xylenesulfonic acid and can be racemized in glacial acetic acid 
using Salicylaldehyde as the racemization agent. We achieved solid phase homochirality using 
continuous heating-cooling cycles in a suspension of the 2,5-Xylenesulfonic acid salt of 
Phenylalanine with racemization in the solution. A higher cooling rate increases the overall 
deracemization rate while the temperature excursion applied to the system does not have a 
significant effect within the range tested. An initial solid phase enantiomeric excess, a larger 
amount of catalyst used for the solution phase racemization or a smaller total amount of solid 
in the system also boost the deracemization. A comparison suggests that the temperature 
cycling method, when suitable operational conditions are applied, has a higher deracemization 
rate than the grinding method (Viedma Ripening) to achieve an enantiomerically pure solid 
phase.  
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4.2 Introduction 
One decade ago, Viedma discovered a method in which an enantiopure solid phase of 
complete homochirality can be formed from an initial suspension having a racemic 
composition, by using intensive mechanical grinding.1 He applied this method to the system 
of sodium chlorate (NaClO3), an achiral compound whose crystals show optical activity.2 This 
method, now called Viedma Ripening, includes Ostwald Ripening as one of its mechanisms, in 
which large crystals grow at the cost of small ones.3 Noorduin et al. extended the application 
of Viedma Ripening to chiral molecules, by bringing in a solution phase racemization reaction.4 
A few years ago, Coquerel and his group demonstrated an alternative technique, in which a 
combination of convenient heating-cooling cycles and a solution phase racemization reaction 
was used to reach complete chiral symmetry breaking of the crystal phase without the need 
to grind the suspension.5  
Although both Viedma Ripening and the temperature cycling method can lead to a full 
deracemization of the solid phase, their application is restricted. One of the requirements for 
a chiral compound to be deracemized by either of the two techniques is that it should 
crystallize as a conglomerate, a mechanical mixture of enantiomerically pure crystals.6 This 
requirement is rarely fulfilled since more than 90% of the chiral molecules crystallize as 
racemic compounds, crystals in which the molecules of both enantiomers are homogeneously 
distributed.6 In order to overcome this restriction, a racemic compound has to be transformed 
into a conglomerate system. Noorduin et al. deracemized the racemic compound Naproxen by 
chemically converting it into its conglomerate-forming ester.7 Although this method of 
chemical derivatives formation can be applied, it has the drawbacks of product loss and long 
operation time. Recently, Spix et al. deracemized Phenylalanine via its conglomerate-forming 
salt with 2,5-xylenesulfonic acid by mechanical grinding, which expands the application of 
Viedma Ripening.8 
Phenylalanine is an essential amino acid and plays a key role in the biosynthesis of other 
amino acids and some neurotransmitters.9 DL-Phenylalanine crystallizes as a racemic 
compound while its salt with 2,5-Xylenesulfonic acid forms a conglomerate. Here we aim to 
investigate whether programmed temperature cycles can also lead to the solid phase 
homochirality of the same system. To our knowledge this is the first time the novel 
deracemization route using temperature cycling is combined with the conversion of a racemic 
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compound to conglomerates. Moreover, we have investigated the effects of different 
operational parameters, such as the cooling rate in each of the temperature cycles, the total 
amount of solids and the amount of catalyst on the deracemization rate. In addition we 
compared the rate of Viedma Ripening to that of temperature cycling  in achieving an 
enantiomerically pure crystal phase.  
 
4.3 Experimental  
4.3.1 Materials 
Solute and catalyst were purchased from Sigma Aldrich (DL-Phenylalanine (DL-Phe, 
99%), D-Phenylalanine (D-Phe, 98%) and Salicylaldehyde (SAH, 98%)), Merck (L-
Phenyalanine (L-Phe, 99%)) and Alfa Aesar (2,5-Xylenesulfonic acid (XSA, 99%)). Glacial 
acetic acid was purchased from J. T. Baker (99-100%). MilliQ water and Acetonitrile (99%) 
from Sigma Aldrich were used as effluent for chiral HPLC analysis. Acetone (99%, Sigma 
Aldrich) was used as washing solvent during sampling.  
Phenylalanine can be racemized in glacial acetic acid, catalysed by Salicylaldehyde. This 
reaction works optimally at a temperature of 100°C but can still achieve sufficient racemization 
at relatively lower temperature (e.g. 65°C). One problem of using this reaction in the present 
study is that only free amino acid, which is not bonded with 2,5-Xylenesulfonic acid, can be 
racemized via the formation of a Schiff base.10 To solve this problem we added slightly less 
2,5-Xylenesulfonic acid to the system so that part of the Phenylalanine (ca. 10%-15%) has 
an unprotonated amino group that can form a Schiff base and racemize readily.  
 
4.3.2 Verification experiments  
We performed three experiments to determine whether deracemization can be achieved 
using temperature cycling instead of grinding with glass beads. The experiments were carried 
out as follows: in the standard experiment A1, 580 mg DL-Phe and 589 mg XSA were mixed 
with 9 mL glacial acetic acid in a 10 mL round-bottom flask. In experiment A2 and A3, 
additionally, 58 mg of L-Phe or D-Phe respectively were mixed into the suspensions. The 
suspensions in all experiments were stirred by an oval PTFE-coated magnetic bar (L 20 mm, 
Ø 10 mm, 300 rpm) at 65°C for 1 hour. Then we applied two different temperature programs 
to the suspensions, which are shown in Figure 4.1. The first temperature profile TP1, which 
was applied in experiment A1 and A2, consisted of four steps: holding at 65°C for 5 min, 
heating up to 70°C in 10 min, holding at 70°C for 5 min and finally cooling down to 65°C with 
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a cooling rate of 0.06°C/min. We assigned the other temperature profile TP2 to A3, and its 
only difference compared with TP1, was a cooling rate of 0.12°C/min.  
 
 
Figure 4.1. Temperature profiles applied in the verification experiments A1-A3. A1 and A2 used a cooling rate of 
0.06°C/min (TP1), while that of A3 was 0.12°C/min (TP2).  
 
After two rounds of the above mentioned temperature cycles, 90 mg of SAH was added 
to the suspensions at 65°C to start the racemization reaction. The temperature cycles were 
continued until the deracemization was substantial. Samples were taken over time to measure 
the solid phase enantiomeric excess ee using chiral HPLC. 
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4.3.3 Operational parameter test  
 
Five operational parameters were tested for their effects on the deracemization rate. 
These parameters included: the difference between the lowest and the highest temperature 
(ΔT) in a temperature cycle, the rate of cooling from the highest to the lowest temperature 
(cooling rate), the prepared enantiomeric excess in the solid phase i.e. before it was mixed 
with acetic acid (eeprep), mass of the solid phase before it was mixed with acetic acid (m0) and 
the amount of catalyst used (mc). We applied three different temperature profiles (TP3-TP5) 
in order to test the effects of temperature excursion and the cooling rate (see Figure 4.2).  
 
Figure 4.2. Temperature profiles applied in the parameter tests to investigate the effect of temperature excursion 
and cooling rate.  
Table 4.1 gives a summary of the values of the key parameters used in all the 
deracemization experiments in this study.  
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Table 4.1. Deracemization conditions used in this study. 
Experiment eeprepa m0 (g)b 
mc 
(mg)c 
ΔT (°C)d 
Cooling 
rate R 
(°C/min) 
Temperature 
 Profile 
A1 0 1.23 180 5 0.06 TP1 
A2 0.091 (D) 1.23 180 5 0.06 TP1 
A3 0.091 (L) 1.23 180 5 0.12 TP2 
B1 0.091 (L) 1.23 180 15 0.5 TP3 
B2 0.091 (L) 1.23 180 15 0.3 TP4 
B3 0.091 (L) 1.23 180 10 0.3 TP5 
B4 0.091 (L) 0.86 180 15 0.5 TP3 
B5 0.091 (L) 1.23 90 15 0.5 TP3 
B6 0.091 (L) 1.23 360 15 0.5 TP3 
B7 0 1.23 180 5 0.12 TP2 
a eeprep :the initial ee of the solid phase before being mixed with acetic acid.  
b m0  :the mass of the solid phase, including all Phe and XSA, before being mixed with acetic 
acid.  
c mc  :the mass of catalyst added to the suspension.  
d ΔT  :temperature excursion, the difference between the highest and the lowest 
temperature. 
The prepared enantiomeric excess of the solid phase, eeprep , is defined as:  
 
 
𝑒𝑒𝑝𝑟𝑒𝑝 =
𝑚𝐷−𝑚𝐿
𝑚𝐷+𝑚𝐿
  (1) 
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Here mL is the mass of L-Phe in the solid phase, before being mixed with XSA and 
analogously for mD.  
4.4 Results and discussion 
4.4.1 Deracemization through temperature cycling  
The first part of the experiments aimed to prove that by using the temperature cycling 
method, the conglomerate-forming amino acid salt can be deracemized. Figure 4.3 depicts 
the evolution of the solid phase ee and lnee over time in all three verification experiments.  
 
Figure 4.3. Evolution of enantiomeric excess ee (a) and ln ee (b) versus time t in temperature cycling 
deracemization experiments A1 (●), A2 (▲) and A3 (■). The enantiomeric excess ee develops 
exponentially in time as can be seen from the linear fit to the experimental data points in (b).  
All three verification experiments led to a complete deracemization in the solid phase. 
Experiments A2 and A3 ended in the enantiomer initially in excess. For A1, where the initial 
enantiomeric excess eeprep was equal to zero, a complete deracemization towards the L-
enantiomer in the crystal phase was obtained. An exponential increase of the ee was observed 
in time, similar to what has been reported in earlier deracemization studies using grinding 
(Viedma Ripening) and temperature cycling.5, 11 The time dependence of the deracemization 
is given by the equation 
𝑒𝑒 = 𝑒𝑒0 ∙ exp(𝑘𝑡) 
which describes Viedma Ripening in terms of two parameters: ee0, the solid phase 
enantiomeric excess in the beginning of the deracemization, i.e. after dissolution of the 
compound with prepared enantiomeric excess and the rate constant k (h-1).12 To investigate 
the effects of various operational conditions, we used this rate equation to fit all the 
experimental data from this study to compare their rate constants k.  
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4.4.2 Effect of the operational conditions on the deracemization rate  
The influence of various operational parameters on the deracemization rate constant k 
was tested. The first parameter tested was the cooling rate R from the highest to the lowest 
temperature in each temperature cycle. The results of the experiments with different cooling 
rates are depicted in Figure 4.4. Experiment B1 with a cooling rate of 0.5 oC/min had twice as 
high a rate constant for deracemization than experiment B2, in which a cooling rate of 
0.3oC/min was used (k = 0.055 h-1 versus k = 0.027 h-1). Moreover the number of cycles 
needed for full deracemization was less in B2, which is as expected, but opposite to what has 
been reported before.5 In the previous work the observed decrease in deracemization rate at 
higher cooling rates was attributed to primary nucleation. When a high cooling rate is applied, 
a higher supersaturation is created which makes it more probable for primary nucleation of 
the enantiomers present in minor amount to occur. This would lead to a slower 
deracemization. In this study an opposite trend was observed. Apparently the primary 
nucleation of D-Phe-XSA, the minor enantiomer here, did not take place for the cooling rates 
applied here.  
-  
Figure 4.4. The effect of cooling rate on the deracemization. The experimental (symbols) and fitted (solid lines) 
enantiomeric excess ee versus time t (a) and number N of cycles (b) for experiments B1 (●) and B2 
(■).  
The second parameter tested was the temperature excursion ΔT, which is the difference 
between the lowest and the highest temperatures in the temperature cycles. In Figure 4.5, 
the results of experiment B2 are compared with those of B3, in which a smaller temperature 
excursion of 10°C was used.  
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Figure 4.5. The effect of temperature excursion ΔT on the deracemization. Evolution of experimental (symbols) 
and fitted (solid lines) enantiomeric excess ee versus time t (a) and number N of temperature cycles 
(b) in experiments B2 (▲) and B3 (■). 
 
Figure 4.5 shows that it took approximately 43 hours or 43 cycles to completely break 
the solid phase symmetry in experiment B3, while in B2, the time needed for full 
deracemization was 47 hours or 35 cycles. The comparison of the rate constant (0.027 h-1 for 
B2 versus 0.030 h-1 for B3) also shows that a larger temperature excursion in B2 did not bring 
the system faster to homochirality, the deracemization was slightly slowed down because of 
the longer time needed for each temperature cycle. This is similar to what has been found in 
the earlier study, where a smaller temperature excursion led to a shorter time for full 
deracemization.5  
Besides the temperature profile, the initial enantiomeric excess ee0 , also plays an 
important role in the deracemization process. This is observed when comparing two 
experiments with different eeprep (0 and 0.091(L)) in Figure 4.6(a). In experiment B7, where 
eeprep=0, the ratio between the two enantiomers in the solid phase did not change during the 
first 90 hours. In the same period of time, complete deracemization of the solid phase in the 
other system (A3) was achieved. These two cases are difficult to compare, however, as 
starting from a racemic situation in Viedma ripening is known to lead to an initial time interval 
in which the ee stays more or less zero. This is interpreted in terms of a threshold ee value 
needed for the autocatalytic increase to become effective. The time needed for this probably 
depends on local fluctuations in the system.13 Leaving out this initial time interval in the fit 
results in a rate constant k =  0.016 h-1 for A3 and k = 0.015 h-1 for B7. One would expect 
the values for k to be identical as just the ee0 changes in this case. After leaving out the initial 
time the values are indeed close.  
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Figure 4.6. Evolution of ee versus time with different (a) eeprep and (b) m0. In (a), initial solid phase eeprep of 0 and 
0.091 (L) were used in experiment B7 (●) and A3 (♦), respectively. In (b), total solid phase mass m0 of 
1.23 g and 0.86 g were used in experiment B1 (■) and B4 (▲), respectively. 
  
In experiments B1 and B4 different values for m0, the total mass of solid phase, were 
used. Complete deracemization was achieved faster when less solids were used (B4), as can 
be seen in Figure 4.6(b). This effect was also found in both Viedma ripening and the 
temperature cycling method for other systems.5, 11 It is attributed to the larger fraction of 
solids that has to be converted in the dissolution-growth cycles. Here this explanation is 
explored further and connected with the surface area of solid phase available for crystal 
growth. As is demonstrated in Figure 4.7, the mass m0 which was added in the beginning of 
the experiments (B1 and B4) can be divided into three parts: the part which was dissolved in 
the solution throughout the whole experiment (I), the part which was dissolved and regrown 
during each heating-cooling cycle (II) and the part which remained undissolved even at the 
highest temperature (III). The parts I and II of the mass were the same for both experiments 
B1 and B4. However, part III of the mass in B4 was smaller than that  in B1. As a consequence, 
L4/D4, the mass ratio of L- to D-Phe-XSA crystals in B4, was larger than L1/D1, its counterpart 
in B1. If we assume that the crystals in both experiments had  similar size distributions, the 
surface area ratio of L- to D-Phe-XSA crystals was also larger in B4. This would lead to a 
higher growth rate difference between the L and D populations if it is assumed that the 
racemization in the solution is not rate limiting and that the dissolution in the heating phase 
has no influence on the relative amounts of the D and the L phase crystals. The difference in 
mass growth between the L and the D crystals would therefore lead to an amplification of 
asymmetry and thus to an increase in the rate of the deracemization in the system where a 
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lower amount of solid was present. This interpretation, however is difficult to prove and more 
specific experiments are needed.  
 
 
Figure 4.7. Schematic representation of the total mass distribution during temperature cycling in experiments  
B1 and B4.  
The last parameter tested was the amount of catalyst used for the solution phase 
racemization reaction. Its effect on the deracemization rate using Viedma ripening has been 
investigated by Noorduin et al. and the conclusion is that the deracemization rate increases 
linearly with the amount of catalyst.11 We observed a similar trend in this study, as is illustrated 
in Figure 4.8. The k-values for the different experiments are: 0.034 h-1 (B5 / 90 mg), 0.055 h-
1 (B1 / 180 mg) and 0.203 h-1 (B6 / 360 mg). This means that the deracemization rate is 
increasing with increasing mc, although rather in an exponential than linear fashion. We 
assume that the solubility increases with a higher amount of catalyst, due to the formation of 
the Phenylalanine Schiff base. This would lead to a lower amount of crystals that need to be 
deracemized and a higher racemization speed due to more catalyst. These two parameters 
would amplify the effect that the amount of catalyst has on the deracemization speed and 
they can explain the nonlinear correlation. 
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Figure 4.8. Evolution of ee in time for different catalyst amounts, mc of 90 mg, 180 mg and 360 mg, used in 
experiments B5 (▲), B1 (●) and B6 (●), respectively.  
 
4.4.3 General comparison between temperature cycling and Viedma 
Ripening 
 
The time constants of all the deracemization experiments performed are gathered in 
Figure 4.9. The deracemization rate of the same salt system using Viedma ripening is also 
included in this graph.8 The deracemization rates in the verification experiments A1 to A3 are 
in the same range as the ones found for Viedma Ripening, conducted with comparable 
amounts. With modification in some of the operational conditions, such as the amount of 
catalyst, this rate of complete symmetry breaking is significantly increased. This indicates that 
a faster deracemization can be achieved by applying the temperature cycling method using 
suitable operational conditions. However, one should bear in mind that neither of these two 
methods has been fully optimized and the present comparison of deracemization rates should 
only be considered an indication. From an industrial point of view, the temperature cycling 
method does have several advantages: 1) It is easier to scale-up than the grinding method, 
because an industrial-scale Viedma Ripening will require a much thicker crystallizer wall for 
the mechanical impact and the corresponding risks and maintenance costs will be higher. 2) 
The solid phase from Viedma Ripening still needs additional steps to separate the crystals 
from the beads, which will lead to product loss. Due to these disadvantages and the possible 
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higher deracemization rate, the temperature cycling method in this study is considered to 
have more potential in industrial applications.  
 
Figure 4.9. Deracemization rate constant k using the temperature cycling method (A1-B7) and the grinding method 
(VR1-VR3).8 Two different values for eeprep were used in the grinding method, 0 (VR1) and 0.091 (L) 
(VR2 and VR3). The error bars are absolute deviations of k from fitting the exponential equation to the 
experimental data. 
 
4.5 Conclusion 
 
In the present study, it is shown that a chiral molecule, which crystallizes as a racemic 
compound, can be deracemized using the temperature cycling method, through a 
conglomerate-forming salt. This strategy should be applicable to other chiral molecules 
forming racemic compounds. Moreover, the studied effects of operational parameters give 
insight in the influence of various process conditions on the deracemization rate. Such 
information will be of help in the exploration of the mechanism behind the temperature cycling 
method, which is still not resolved. This in turn will aid the design and optimization of 
corresponding industrial equipment. A comparison of the deracemization rate using Viedma 
Ripening and the temperature cycling method suggests the potential of the latter one as a 
faster and more versatile choice for industry. Further research is however needed to test the 
general validity of this advantage of temperature cycling.  
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Chapter 5 
Resolution of Asparagine in a coupled batch 
grinding process 
5.1 Introduction 
Large amounts of optically active substances are produced industrially. To obtain 
enantiomerically pure compounds mainly two approaches are adopted: enantioselective 
synthesis where one gets an enantiomerically enriched or even pure product already during 
the synthesis, or crystallization, which is employed after the synthesis of a racemic mixture. 
The purification via crystallization is performed with diastereomers making use of their 
difference in solubility or by the technique to which Amiard gave the name resolution by 
entrainment1 (dédoublement par entraînment).2 The latter approach, which is limited to 
racemic conglomerate forming chiral compounds, is often referred to as preferential 
crystallization, and starts with a racemic solution. After adding an enantiomerically pure seed 
crystal to the initially supersaturated solution, crystallization begins. In this way one can obtain 
enantiomerically pure crystals from a racemic solution. The crystallization, however, must be 
stopped on time to avoid primary nucleation of the enantiomer of the other handedness. The 
yield is rather low but can be increased by conducting several crystallization runs with 
alternating handedness for the seed crystals.2 Moreover, adding a racemization catalyst to the 
solution makes it possible to convert all supersaturation to the handedness of the seed crystal, 
implying an enantiomerically pure yield only limited by the solubility of the racemate. In such 
a case, one speaks of a total spontaneous resolution process. 
In many cases, however, the compound of interest is impossible to racemise or 
racemization is too difficult under the conditions of the total spontaneous resolution process. 
A number of methods has been proposed to still resolve the compound with a good yield.  
By using seed crystals of opposite handedness in two separated vessels, but with 
exchange of the solution between them, both enantiomers can be crystallized with high yield. 
Rousseau et al.3 connected the vessels using a membrane barrier to prevent exchange of 
crystalline material, while Elsner et al.4 pumped liquid between two vessels, see figure 5.1. In 
both cases, if the exchange in liquid is fast enough the solution ee stays around 0 % and the 
crystallization of the wrong enantiomer is prevented. 
Resolution of Asparagine in a coupled batch grinding process 
 
46 
 
Figure 5.1. Two coupled entrainment experiments. (a) A membrane is preventing the exchange of crystals. The 
liquid flow occurs by diffusion through the connection between the two vessels. (b) Coupled batch 
experiment. The liquid is pumped through filters from one vessel to the other. This enables a steady 
solution ee around zero and increases the yield of the preferential crystallization. In the vessels seed 
crystals of opposite handedness are used.    
 
Hein et al. recently also used two vessels and pumped the solution around.5 They did 
not use preferential crystallization, but were inspired by the deracemization experiments of 
Viedma.6 Enantiomerical purity in so-called Viedma ripening experiments arises through 
vigorous grinding of a scalemic mixture of crystals in the presence of a racemization reaction 
in solution. As for total spontaneous resolution, without a racemization reaction Viedma 
ripening is not possible. Coupling two vessels and exchanging the solution using pumps is also 
here a way to replace a racemization reaction.  
 
Figure 5.2. Resolution by crystal-size-induced solubility differences. (a) In the left vessel a racemic mixture is 
vigorously ground and in the right vessel some enantiomerically pure seed crystals are mildly stirred. 
(b) In the central vessel a racemic mixture is vigorously ground using ultrasound and the right and left 
vessel, containing some enantiomerically pure seed crystals of opposite handedness, are mildly 
stirred. The solution exchange guarantees an almost saturated racemic solution in both vessels. 
Hein et al. used two different setups. The first was conducted with sodium ammonium 
tartrate. In one vessel, a racemic conglomerate of the crystals was vigorously ground and the 
other, containing some seed crystals of sodium-ammonium (D)-tartrate, was mildly stirred. 
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Both vessels were kept at the same constant temperature. In the end the vessel with the seed 
crystals contained highly pure D-crystals while the other ended up with L-crystals (>98 % 
enantiomeric excess).  
The second setup was conducted with Threonine. In this case, they used three different 
vessels between which the solution was exchanged using pumps. The vessel with the racemic 
crystals was kept at 35 °C and sonicated in the presence of glass beads. The two other vessels 
were kept at 20 °C and mildly stirred. They contained a saturated racemic solution in contact 
with L and D seed crystals respectively. The high temperature vessel with the racemic crystals 
was free of crystals at the end of the experiment and the other two vessels contained highly 
pure Threonine crystals of L and D handedness respectively. Both experiments of Hein et al. 
exploited the crystal-size-induced solubility difference as a result of the Gibbs-Thomson effect7 
to separate the enantiomers, although in the three-vessel experiment this effect was amplified 
by the temperature difference.  
The major advantage of Viedma ripening when compared to total spontaneous 
resolution is its robustness. Since the supersaturation, is virtually zero nucleation of the 
unwanted enantiomer is avoided. This makes Viedma ripening a more robust process. The 
experiments of Hein et al. are not easy to perform because, the different vessels have different 
functions and or temperatures and exchange of crystalline material ruins the outcome. We 
therefore demonstrate here a modified approach in which two connected vessels both contain 
crystals that are ground and are kept at a constant temperature, see figure 5.3.  
5.2 Results and discussion 
We use Asparagine (Asn) as a model compound. The monohydrate of Asparagine forms 
a stable conglomerate. Amino acids including Asn are racemisable in acetic acid with 
salicylaldehyde at elevated temperatures.8 Nevertheless Asn is not a candidate for Viedma 
ripening, because the racemic conglomerate is not stable in hot, hygroscopic acetic acid and 
is transformed over time into an anhydrous crystal structure which is a racemic compound. 
This makes Asn a good compound to test the coupled batch grinding method. 
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Figure 5.3. Illustration of the experimental setup combining two grinding experiments in coupled batch operation 
mode, for which the racemization reaction is replaced by a solution exchange between the two 
processes.  
The experiments were conducted with Asparagine monohydrate (Asn . 1 H2O). Around 
1.5 g (RS)- Asn . 1 H2O was combined with 0.07 g of (R) or (S)- Asn . 1 H2O respectively and 
25 mL MilliQ water. The slurry was stirred in the presence of 11 g glass beads for at least 3 
days to ensure a homogeneous and equal crystal size distribution for both vessels. The vessels 
had a small and opposite ee. After that, the initial sample was taken and the pumping was 
started. Further samples were taken over time and analyzed using chiral HPLC (see 
experimental details for further information).  
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Figure 5.4. Evolution of the solid phase enantiomeric excess of coupled batch grinding experiments. Lines are a 
guide to the eye. Typical resolution times under the given conditions ranged from 30 – 100 hours. 
 
Figure 5.4 shows the enantiomeric excess in the solids as a function of the sample time. 
The different vessels did not reach 100 % ee at the same time. This was observed in all 
experiments. This is probably caused by a minor impurity that hampers the growth of the (R)- 
Asn . 1 H2O, but this does not interfere with a successful outcome of the experiments. In the 
end one obtains enantiomerically pure (S) and enantiomerically pure (R) Asn monohydrate 
crystals.  
The yield of this experiment is 100 % of the solid phase. The only loss is due to the 
solubility. If just one enantiomer is of interest, the other one could be racemized and 
reintroduced in the process. After the racemization in acetic acid, however, it would crystallize 
as an anhydrous racemic compound, hence a recrystallization from water would be necessary 
to recover the Asn . 1 H2O conglomerate structure.  
5.3 Conclusion 
This coupled batch grinding method is a valid alternative to Viedma ripening for 
compounds that form a stable conglomerate but are not racemizable, or for compounds where 
the racemization reaction and the conglomerate crystal structure require different conditions. 
As a near equilibrium method, the temperature remains constant during this coupled batch 
grinding. Unlike crystallization processes, the end state of a grinding experiment is robust as 
no nucleation of the unwanted enantiomer occurs and the ee remains 100 %. The main 
difference with Viedma ripening is that the latter is a real deracemization process converting 
all solids to a single enantiomer, while the coupled batch grinding method is a 100 % 
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resolution process with a yield of 50 % (R) and 50 % (S) separated crystals. The process can 
be conducted in a semi-continuous mode by filtering off part of the crystals from both 
containers once the 100 % resolution is reached, followed by replenishing the containers with 
a racemic mixture of the conglomerate crystals.  
 
5.4 Experimental details  
 
 
Figure 5.5. Picture of experimental setup. 
The grinding was performed in round bottom flasks (50 mL), put in two tempering 
beakers, connected in parallel to a JULABO (F25) thermostat. Two magnetic stirrers (IKA RCT 
basic) with digital display to adjust to an identical stirring speed for both flasks were used to 
drive the magnetic stirrer inside the flasks. The solution was pumped using two peristaltic 
pumps, either a self-constructed pump or a commercially available one (Heidolph, Pumpdrive 
5001).  
For the crystal-free solution exchange poroplast cannula filters were used. They were 
connected to the plastic tubing of the pump via 3 mm stainless steel tubes. To monitor the 
liquid level easily, a graduation of the volume was added to the round bottom flask.  
A typical experiment was conducted with 1.5 g (RS)-Asparagine ((RS)-Asn) and 0.075 g 
(R) or (S)-Asn respectively. The amino acid was suspended in 25 mL MilliQ water together 
with 11.4 g glass beads (2 mm VWR) and stirred with 700 rpm at 20 °C. The crystals were 
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ground for at least 3 days, without any liquid exchange, to get a homogeneous crystal size 
distribution at the start of the purification step.  
The pumping needed some attention. The poroplast cannula filters were prepared by 
shortening them from about 2 cm to about 1.3 cm, so less false air would be pumped. To get 
the pumping started the filters were submerged completely so they were soaked with the 
liquid. After the pumping was started the filters were rearranged in such a way that just 0.3 
– 0.5 cm was submerged. The disadvantage of this setting is the fact that some air is 
constantly pumped. The liquid level, however, can be held rather constant by this trick as it 
outbalances the false air pumping. For the same reason it is difficult to determine exactly how 
much of the solution was pumped per minute. The pump was running at maximum speed and 
the flow rate depended on the amount of air that entered the tubes and the condition of the 
filters. The filters were cleaned daily (1 to 2 times), to remove the crystals sticking to it.  
Samples were taken over time by extracting 0.5 mL of the slurry with a pasteur pipette 
and filtered quickly over a glass filter (P4). The residue was washed with some acetone to 
remove the solvent and to dry the crystals faster. The crystals were later analyzed using chiral 
HPLC.  
HPLC sample preparation: 1 mg solid in 1 mL Milli Q water, injection volume 5 μL, HPLC 
column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent ethanol/water 50/50 v/v, flow 
0.8 mL/min, detection λ=205 nm, column temperature 35 °C. Retention times (S)-Asn 
6.1 min, (R)-Asn 7.2 min.   
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Chapter 6 
Pitfalls during Viedma ripening – 
deracemization of N-Acetyl-Leucine as an 
example 
6.1 Introduction 
Viedma ripening is an elegant method to receive enantiomerically pure compounds from 
a mixture of racemic conglomerate crystals.1 During this process, crystals are ground in a 
saturated solution, in which a racemization reaction takes places, and evolve over time into 
an enantiomerically pure end state. Just like in a recrystallization process the compound is 
purified; minor impurities remain in the solution. The performance of Viedma ripening is fairly 
simple, once the appropriate conditions are established. The development of Viedma ripening, 
however, has its pitfalls. Here we give an overview of the most common pitfalls and how to 
avoid them. As an example of a troublesome Viedma ripening case, the deracemization of N-
Acetyl-Leucine is discussed. 
Typically, a Viedma ripening experiment is conducted by suspending a scalemic or 
racemic mixture of crystals in a solvent in the presence of glass beads. The crystals will partly 
dissolve. The crystals are then ground in the slurry to establish a more homogeneous crystal 
size distribution. After that the time t = 0 sample is taken and the catalyst that enables the 
racemization reaction is added. Further samples are taken over time and analyzed using for 
example chiral HPLC to follow the development of the solid phase enantiomeric excess (ee) 
over time. The ee is defined as  
𝑒𝑒 =  
𝑛𝑅−n𝑆
𝑛𝑅+n𝑆
 ×  100%, 
where nR and nS are the amount of R and S enantiomers respectively. Instead of grinding 
the crystals it is possible to use a temperature cycling program which leads to a similar 
deracemization.2  
Viedma ripening has two major requirements; first, the molecule of interest must be 
racemisable in solution and second, the compound must crystallize as a racemic conglomerate, 
that is, a racemic mixture of enantiomerically pure crystals.  
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6.1.1 Racemization 
It is advisable to first find a feasible racemization reaction through literature research 
and experiment. In some cases it will be impossible to racemize the molecule of interest, 
which then is an improper candidate for Viedma ripening. Mild racemization conditions in 
terms of temperature and pH are preferable. There are also cases that molecules racemise 
too easily. This is in principle an advantage for Viedma ripening, but it brings also a risk. 
Isoindolinones, for instance, racemise readily when dissolved in ethanol without any catalyst.3 
If one is unaware of this fact, the molecules could racemise during the HPLC measurements 
when conducted with ethanol and the measured enantiomeric excess (ee) would be too low 
or even zero, falsely indicating that the Viedma ripening process is not working. Stabilizing 
the isoindolinones in ethanol with some acetic acid allows to determine the correct ee of the 
solid phase and reveals that the Viedma ripening process works perfectly well for these 
compounds.3  
6.1.2 Racemic conglomerate 
After having a molecule of interest that is racemizable or even better a group of 
molecules, the other requirement of a conglomerate crystal structure must be fulfilled. Around 
10 % of intrinsically chiral organic molecules crystallize as a racemic conglomerate. This means 
that 90 % crystallize in the undesired structure of a racemic compound. There are three 
alternative options when the molecule of interest crystallizes as a racemic compound. (1) It is 
sometimes possible to make a derivative of the compound that forms a racemic 
conglomerate.1b (2) In rare cases the compound forms a metastable conglomerate that 
enables Viedma ripening.4 (3) Combine the molecule with a different compound (a form of 
crystal engineering). An example of option (3) is the formation of a salt of the compound, 
which is in most cases easily conducted and leads to a different crystal structure. By varying 
the counter ion, it should be possible to find a conglomerate crystal structure (one in ten 
compounds will on average be a racemic conglomerate). The salt formation, however, can 
interfere with the racemization reaction. The first example of enabling Viedma ripening of a 
racemic compound by transforming it to a conglomerate salt was the complete deracemization 
of phenylalanine 4-xylenesulfonic acid and alanine 4-chlorobenzenesulfonic acid.5 The 
protonation of the amino group however prevents the formation of the Schiff base that is 
crucial for the racemization reaction and therefore inhibits this reaction. In this special case 
the racemization reaction could still be realized by adding some pure amino acid. 
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The amount of glass beads has also an influence on the rate of Viedma ripening. Often 
the grinding force that is necessary for a successful experiment is underestimated.3, 6 The 
recommendation therefore is to rerun the experiment with a higher amount of glass beads 
and, if possible, higher stirring speed. With strong grinding even the enantiomeric directional 
influence of minor chiral impurities can be overcome.7 The other possibility is temperature 
cycling replacing the grinding which often leads to a faster deracemization reaction.2 
During grinding it can happen that some of the crystals are attached to the glass of the 
vessel or the stirring bar; a form of scaling. The racemic solution then starts crystallizing on 
the crystals, because there is hardly any attrition in these spots and the enantiomeric excess 
of the complete solid phase decreases. Therefore scaling should be avoided or at least 
terminated immediately. As soon as the attrition is restored the effect is reversed.  
Viedma ripening experiments are typically started from a scalemic mixture of solids 
(depicted in scheme 6.1 left). When the experiment is started, solvent is added to the mixture 
and a part of it dissolves. Conglomerates tend to dissolve with a eutectic ee of 0 %.8 This 
means the same amount of the R and S enantiomers are dissolved, as depicted in scheme 6.1 
(middle). Therefore, the excess of the S enantiomer in this example stays the same while the 
total amount of crystals becomes less. This leads to a higher ee in the solid phase. This 
phenomenon is observed regularly during Viedma ripening. The measured ee is always higher 
than expected from the initial amounts used for the experiment. How much the measured and 
expected ee deviate, depends on the solubility of the compound. Therefore, to check whether 
an increase in ee is due to the Viedma ripening process, it is necessary to always determine 
the yield of the deracemization and compare it with the expected yield, based on the solubility 
of the compound. Usually the solubility of the compound does not change during Viedma 
ripening, but the solubility can increase slightly during the process due to the intense grinding 
which leads to smaller crystals which have a higher solubility according to the Gibbs-Thompson 
effect. This effect, however, is minor and usually the yield after a couple of hours grinding 
without catalyst and after a complete deracemization experiment are almost identical.4-5 
Raising the temperature usually leads to an increased solubility and therefore to an increased 
enantiomeric excess for the solids. The higher solubility, however, leads on the other hand to 
a reduced yield, so the recommendation is to keep the temperature as low as possible.  
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Scheme 6.1. Illustration of the effect dissolution has on the solid phase enantiomeric excess Light blue indicates 
the part of the solids that is dissolved. The enantiomeric excess in the solids is larger in the middle 
case as compared to the initial situation (left). In the extreme case in the right the enantiomeric 
excess becomes 100 %. 
 
6.2 N-Acetyl-Leucine as an example 
N-Acetyl-Leucine is widely used in France as a drug to treat acute vestibular vertigo.9 
Furthermore, it is an interesting case in the light of compounds with pitfalls for Viedma 
ripening. It forms a stable racemic conglomerate (see figure 6.1). According to Hongo et al. 
N-Acetyl-Leucine racemises readily when heated in acetic acid in the presence of some acetic 
anhydride.10 A preferential crystallization combined with a racemization reaction for N-Acetyl-
Leucine was published by the same authors.11 In a seeded preferential crystallization 
experiment under racemizing conditions, they were able to obtain optical purity of 96 – 99 % 
in the solids with a yield of 70 %. 
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Figure 6.1. X-ray powder diffraction pattern of N-Acetyl-L-Leucine (red) and the X-ray powder diffraction diagram 
(XRPD) of N-Acetyl-DL-Leucine (black). The racemic and pure compound of a racemic conglomerate 
have the same XRPD.  
 
The compound therefore is expected to be a straightforward candidate for Viedma 
ripening and performing a Viedma ripening experiment at first sight indeed leads to an 
increase in the solid phase enantiomeric excess (ee) (see figure 6.2).  
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Figure 6.2. Deracemization of N-Acetylleucine. All experiments were conducted at 40 °C with a total amount of 1.7 
g N-Acetylleucine, 5 mL acetic acid / acetic anhydride mixture (the amount of catalyst is indicated as 
a volume percentage of the solvent) and 3.35 g glass beads. Lines are a guide to the eye. 
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As mentioned before, however, establishing a Viedma ripening method also requires 
a determination of the yield. First, we determined the expected yield by measuring the 
solubility under grinding conditions in two slurries without catalyst which were ground for 
120 h, then filtered, washed and dried. This results in an expected maximum yield of 59 %. 
Subsequently, four similar experiments were conducted now including the catalyst (see 
table 6.1). 
Table 6.1. Yield experiment overview. All experiments were conducted at 40 °C while stirred at 330 rpm in 4.5 
mL acetic acid and 0.5 mL acetic anhydride. The experiments were terminated after the hours 
mentioned in the table and then the complete solid phase was sampled, dried, weighed and after that 
the ee was measured. 
Terminated after 48 h 72 h 96 h 120 h 
Glass beads 3.357 g 3.353 g 3.351 g 3.355 g 
N-Acetyl-DL-Leucine 1.470 g 1.471 g 1.471 g 1.472 g 
N-Acetyl-L-Leucine 0.198 g 0.194 g 0.198 g 0.196 g 
(total) 1.668 g 1.665 g 1.669 g 1.668 g 
Initial ee (calculated) 11.9 % 11.6 % 11.8 % 11.7 % 
Final ee (measured) 98.4 % 98.0 % 97.1 % 96.9 % 
Yield 0.212 g 
(12.7 %) 
0.213 g 
(12.8 %) 
0.211 g 
(12.6 %) 
0.104 g 
(6.3 %)  
. 
As can be seen in table 6.1 all four experiments ended with a good enantiomeric excess 
of the solid phase, close to 100 %. A yield of around 60 % was expected from the solubility 
experiments. The results, however, were unexpectedly low, around 12 %. In the first three 
experiments, it was just slightly more than the amount of N-Acetyl-L-Leucine that was used 
to create a starting ee.  
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These results make it questionable whether deracemization occurred at all or whether 
the compound just dissolved (see scheme 6.1). Therefore, N-Acetyl-L-Leucine was dispersed 
in 5 mL acetic acid at 40 °C. The excess was filtered off after 2 h of stirring and the saturated 
solution was used for a racemization experiment. The racemization reaction was started by 
adding 0.5 mL acetic anhydride; samples were taken over time and analyzed using chiral 
HPLC. Figure 6.3 shows the results of this experiment. The compound racemises completely 
within 3 hours.  
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Figure 6.3. Evolution of the enantiomeric excess of enantiomerically pure N-Acetyl-L-Leucine under racemization 
conditions.  
To rule out the formation of side products, the solid phase and the solute of a 
deracemization experiment were analyzed using 1H-NMR. In both cases the NMR showed the 
peaks of pure N-Acetyl-Leucine (see supporting information). There were no side products 
detected. This means that a side reaction is not responsible for the increase in solubility and 
the extremely low yield of the deracemization of N-Acetyl-Leucine.  
It could be observed with the naked eye that while conducting a Viedma ripening 
experiment with N-Acetyl-Leucine the compound slowly dissolved. The slurry got more 
transparent over time and it was more difficult to get a sufficient amount of crystals out of 
the slurry with every new sample. This effect seems to be related to the presence of the 
catalyst as it did not occur in the catalyst free experiments.  
Another hypothesis is that a high amount of acid isresponsible for the increased 
solubility. Unfortunately the acetic acid is part of the racemization reaction. It is needed to 
recover the catalyst. Therefore, it cannot be replaced by just another solvent. A new 
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racemization reaction was tested in which the same amount of catalyst as in the other 
experiments (0.5 mL acetic anhydride) was used together with acetic acid in a 1:1 molar ratio. 
As the major solvent isopropanol was chosen. Figure 6.4 (left) shows that this altered 
racemization for Acetylleucine works. Reduction of the catalyst amount (right) leads to an 
insufficient racemization.  
 
Figure 6.4. Evolution of the enantiomeric excess of enantiomercally pure N-Acetyl-L-Leucine under altered 
racemization conditions: 0.5 mL acetic anhydride, 0.3 mL acetic acid and 4.2 mL isopropanol at 40 
⁰C (left). 17 μL acetic anhydride, 10 μL acetic acid and 4.5 mL isopropanol at 40 ⁰C (right). 
 
Considering these racemization results a Viedma ripening experiment was conducted 
with 0.5 mL acetic anhydride, 0.3 mL acetic acid in 4.2 mL isopropanol. Starting with an initial 
ee of 20 % it was enantiomerically pure after 67 h. After this promising result the solubility 
and actual yield were determined. The solubility of Acetylleucine in isopropanol was 
significantly higher than in acetic acid, such that the expected yield would have been around 
20 %. The actual yield that was determined experimentally was again around 12 %. The loss 
was less than in the experiment with acetic acid as a solvent. But it still cannot be called a 
deracemization experiment because the actual yield was the amount of pure N-Acetyl-L-
Leucine that was added in the beginning.  
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6.3 Conclusion 
We introduced here a new racemization reaction for amino acids with a N-Acetyl-group. 
This method gives more flexibility, because one can use different solvents for racemization 
and deracemization. Although exchanging the acetic acid with isopropanol did not lead to a 
higher yield another solvent could give better results, especially when the solubility of N-
Acetyl-Leucine is very low in this particular solvent.  
Conducting a Viedma ripening experiment with N-Acetyl-Leucine and analyzing the 
samples with chiral HPLC led to the deceiving impression that it worked perfectly well (see 
Figure 6.2). The determination of the yield revealed that it was in the order of the previously 
added enantiomerically pure N-Acetyl-L-Leucine. Therefore this cannot be called a 
deracemization reaction. Deracemization should include the actual transformation from one 
enantiomer into the other. The grinding of N-Acetyl-Leucine is rather just an effect of 
purification by partial dissolving of the solid phase as depicted in Scheme 6.1.  
Increased solubility over time like in this example or side reactions can give the illusion 
of a functioning Viedma ripening process. N-Acetyl-Leucine is a perfect example for the 
importance of determining the yield. The determination of the yield is the only possibility and 
therefore the key to the verification or falsification of a deracemization process and should be 
included when reporting a new Viedma ripening method. 
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Chapter 7 
Persistent reverse enantiomeric excess in 
solution during Viedma ripening 
7.1 Introduction 
Viedma ripening is a recent innovation in chiral purification methods.1 In the process of Viedma 
ripening chiral crystals are ground in contact with their saturated solution. Starting from a 
racemic conglomerate of left and right handed crystals, an enantiomerical imbalance formed 
in time leads to an enantiomerically pure end state in the solids. Viedma ripening, is thus more 
a deracemization process than a resolution process, as 100 % of the solids are converted to 
a single enantiomer. The outcome of the enantiomeric end state can be directed, for example, 
by adding a small amount of enantiomerically pure crystals at the start of the process. In the 
case of intrinsically chiral molecules a racemization reaction is needed to convert the right into 
the left handed molecule and vice versa. 
After the first discovery of this deracemization process for the achiral compound NaClO3 by 
Viedma, several examples have been reported in the literature of achiral compounds that form 
chiral crystals and that undergo Viedma ripening.1-2 Meanwhile, many examples of complete 
deracemization of intrinsically chiral molecules for which racemization in the solution is 
necessary have been reported as well.3 It is quite well understood which requirements must 
be fulfilled to make Viedma ripening feasible and also how circumstances like solubility and 
grinding intensity influence the deracemization rate.4 The details of the exact mechanism 
behind Viedma ripening, however, are still under debate.  
Several models have been proposed. After the first deracemization experiments were 
conducted and published by Viedma in 2005, Uwaha proposed a reaction type model to explain 
the process.5 The model featured chiral clusters of the intrinsically achiral compound as 
essential for the full and rapid deracemization. Later, when Viedma ripening was extended to 
the cases of intrinsically chiral compounds,3a several alternative models to explain Viedma 
ripening for chiral molecules were reported.5-6 
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All of these proposed models yield the sigmoidal curves for the enantiomeric excess in time 
that are typically observed during Viedma ripening, which was taken as a proof for their 
correctness. Nevertheless, the best way to confirm or discover the true mechanism of Viedma 
ripening would be direct experimental evidence, for example, for the chiral clusters. Such 
experiments, however, are not easily conducted because the smallest particles in a slurry of 
crystals of different shapes and sizes need to be observed, which is difficult if not impossible. 
Information thus has to come from more macroscopic observations.  
Here we report experiments on the enantiomeric excess (ee) in solution during 
deracemization. Earlier Noorduin et al.6d concluded that during deracemization, the solution 
obtains the opposite ee as the solid. Once the solid ee reaches 100 %, the solution ee should 
become 0%. We find that also when deracemization is complete, the solution has a reverse 
ee. We propose as explanation for this the presence of very small, thermodynamically stable 
clusters.  
7.2 Experimental results 
During Viedma ripening experiments on alanine 4-chlorobenzenesulfonic acid, we conducted 
stability experiments of the enantiomerically pure end state.3m These experiments were 
started with pure (S)-alanine and 4-chlorobenzenesulfonic acid in a 10:9 ratio. The amount of 
all used chemicals was identical to a normal deracemization experiment including the catalyst. 
We then found that the enantiomerically pure end state remains stable for at least 200 hours.  
In addition to the solid state ee we also checked the ee in the solution. Due to racemization, 
this is expected to be 0 %, but we surprisingly found the solution was not perfectly racemic, 
but showed a distinct ee of the (R) enantiomer (between 15 and 20 %).  
Complete Viedma ripening experiments were conducted subsequently, where both the solid 
phase and solution ee were determined as a function of time. The samples were filtered over 
a P4 glass filter and the solution including the washing solvent were collected in a 
Büchnerflask. After evaporating the liquids completely, the resulting crystals from the solution 
phase and the solid phase were analyzed using chiral HPLC (see supporting info for details). 
Note, that the solution samples were taken at 70 °C, a temperature at which the racemization 
process, is still active. Due to the fast drop in temperature of the solution, once removed from 
the experiment, the racemization stops and the solution ee is arrested. 
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Figure 7.1. Attrition-enhanced evolution of solid-phase ee (filled symbols) and solution ee (open symbols) for 
alanine 4-chlorobenzenesulfonic acid; The four separate experiments were conducted at 70 °C. Lines 
are a guide to the eye. 
During the deracemization experiments an ee in the solution was observed which was of the 
opposite handedness as compared to the solid (Figure 7.1; ee 2 – 5 %). The solution ee 
increased along with the solid phase ee until the latter was enantiomerically pure; after that 
the solution ee remained almost constant at around 15 %. If some very small crystals or 
clusters would pass the filter during sampling one would therefore observe a non-zero ee in 
the solution of the same handedness as in the solid state. In other words it is not possible to 
explain the observed solution ee of the opposite handedness. 
Gathering the solution ee sample by filtration bears the risk that in the process the crystals in 
the glass filter, when still in contact with the solution, can grow. Thereby the solution would 
be deprived of the major enantiomer of the solid phase, resulting in an enantiomeric excess 
of the opposite handedness. This would explain the observed phenomena. To rule out this 
effect we went for an in situ method to obtain a crystal free solution from a Viedma ripening 
experiment. Therefore a 1 mL syringe was equipped with a poroplast cannula filter (10, 4 or 
1 micron) and the solution was extracted, free of crystals, at 70 °C directly from the round 
bottom flask. We conducted with this sampling method complete Viedma ripening experiments 
(Figure 7.2a). We also started with enantiomerically pure crystals that were ground and 
racemized in the solution (Figure 7.2b). The first data point was taken shortly before the 
catalyst was added, therefore both the solids and the solution have 100 % ee. The results of 
these experiments are in essence the same as the ones in Figure 7.1.  
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Figure 7.2. Attrition-enhanced evolution of solid-phase ee (filled symbols) and solution ee (open symbols) for 
alanine 4-chlorobenzenesulfonic acid; Experiments were conducted at 70 °C. Solution samples were 
taken with cannula filters (pore size as indicated). Lines are a guide to the eye. 
 
The anomalous solid phase of 90 % at 115 h in figure 7.2b is caused by crystals that were 
stuck to the flask walls and were not ground. When the grinding was re-established the system 
returned to the stable enantiomerically pure end state.  
7.3 Model calculations 
 
7.3.1 Failure of simple cluster model 
 
Noorduin et al. already found an increasing inverse ee in the solution during the 
deracemization process.6d In their paper a simple model, based on earlier work of Uwaha was 
used.5 Here we present an extension to this model to explain the presently observed persistent 
inverse eel as long as the grinding is maintained. The extension involves thermodynamic 
clusters which are always present, even in a (nearly) equilibrium situation. The model used in 
the paper of Noorduin et al. reduces the crystals in the Viedma ripening process to merely 
two sizes; Big crystals, containing B+ and B- molecules altogether, and small crystals or clusters 
due to the attrition, containing C+ and C- molecules altogether. Note, that in the original paper 
the symbols R and S were used instead of + and –. The deracemization process was modeled 
by a set of rate equations with rate constants a for the growth and dissolution of crystals B 
and clusters C with monomers, b for the attrition of big crystals, c for the enantioselective 
incorporation of chiral clusters into big crystals and r for the racemization in the solution. 
Uwaha already claimed that the enantioselective incorporation of the chiral clusters into larger 
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crystals was essential for the auto-catalytic behavior of Viedma ripening, resulting in sigmoidal 
deracemization vs. time plots. 
As soon as the Viedma ripening resulted in an increase of ees the solution enantiomeric excess 
eel turned out to increase also but with opposite sign (see Figure 7.3).6d As can be seen in 
this Figure, the inverse eel increases with increasing ees until total deracemization is reached, 
after which eel rapidly decreases to zero and remains zero.  
 
Figure 7.3. Enantiomeric excess eeS (left) and eel (right) as a function of time. Reprinted from Noorduin et al.6d 
(supporting information); Note the logarithmic scale in the left plot. 
 
Figure 7.4 shows the ongoing processes according to this model once deracemization is 
complete. In the absence of solid material of the ‘-‘ type, the amount of M+  and M- molecules 
has to be equal, the solution ee is predicted to be zero. This is therefore not the appropriate 
model to explain the observed reverse solution ee. 
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Figure 7.4. Final situation of a Viedma ripening experiment with just one enantiomer left in the solid phase 
according to the model of Noorduin et al..6d B represents big crystals, C clusters and M the solute in 
the solution phase. To label the two enantiomers + and – signs are used. The process rate constants 
a, b, c and r are explained in the main text. 
 
7.3.2 Extended model 
The failure of the simple model to explain the reversed solution ee means that the model 
needs a modification. None of the earlier models has the right ingredient to explain our 
observation. Here we propose to extend the simple model by including thermodynamic 
clusters. The model has already two crystal sizes, B and C, but these represent the effect of 
growth and attrition. A solution near equilibrium, however, will also contain very small clusters 
that form and disappear by the spontaneous addition and removal of monomers. We will label 
these thermodynamically stable clusters by CTh. 
As a Viedma ripening process runs under nearly equilibrium conditions, or rather a near 
equilibrium steady state, we, as in the earlier model, assume that the nucleation rate in the 
system is zero. That is, the thermodynamic clusters that are formed spontaneously will never 
reach the size of the critical nucleus, which is relatively large for near equilibrium conditions. 
The extended model is schematized in Fig. 7.5 and is described by the set of rate equations 
(1a-1e), together with the analogous equations for the amounts of molecules with opposite 
sign. 
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Figure 7.5. Schematic view of the processes involved during Viedma ripening according to the 
thermodynamic cluster model including thermodynamic chiral clusters CTh.  
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The thermodynamic clusters are produced spontaneously with a rate constant aTh. To avoid 
too many parameters their production as a result of attrition is neglected. For the same reason 
the thermodynamic clusters are assumed to be enantioselectively incorporated into the big 
crystals only, with rate constant cTh. The production of the thermodynamic clusters depends 
on the deviation from the equilibrium number of monomers in solution, (M+/--MCeq), a measure 
Persistent reverse enantiomeric excess in solution during Viedma ripening 
 
70 
for the supersaturation, and on the analogous deviation in the solids (CTh,eq-C+/-Th). In these 
expressions CTh,eq is the equilibrium number of molecules in the chiral thermodynamic clusters. 
As, apart from the racemization reaction with rate r, we assume no interaction between the 
two enantiomers, C+Th, eq = C-Th, eq = CTh,eq and the value follows the Boltzmann distribution.  
The equilibrium number of monomers in solution for clusters, MCeq, will be larger than MBeq for 
the big crystals due to the Gibbs-Thomson effect.7 For the big crystals the Gibbs-Thomson 
effect is small, and we may thus assume that MBeq corresponds to the concentration in a 
saturated solution. In such a saturated solution, the monomer concentration corresponds 
simultaneously to the equilibrium number of monomers for the thermodynamic clusters. 
Therefore, MCTh,eq = MBeq.  
 
7.3.3 Results of the extended model 
The deracemization process will be described by the enantiomeric excess in the solids as well 
as in the solution in time. For the solids the ee is defined for the big crystals as  
,
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and analogously for the clusters, eeC, and for the thermodynamical clusters, eeCTh. The 
thermodynamic clusters, however, are so small that during sampling of the solids they will 
pass the sampling filter. Therefore, the total experimental solids enantiomeric excess, eeS, will 
in good approximation be equal to  
.
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In the solution the ee is defined as 
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But, due to the small size of the thermodynamic clusters, the total experimental solution 
enantiomeric excess, eel, will be 
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For a numerical integration of the set of rate equations (1), the rate parameters and numbers 
of molecules of the paper by Noorduin et al., which resulted in Figure 7.3, were used, i.e., a 
= 3, b = 0.5, c = 0.2, r =2, MBeq = 1.0 and MCeq = 1.1.6d For the additional parameters in the 
extended model, in first instance, the following values were chosen: cTh = 0.2, aTh = 10.0, 
MCTh,eq = MBeq and CTh,eq = 0.2. This choice leads to the results in Figure 7.6. 
 
 
Figure 7.6. Evolution of the deracemization process during Viedma ripening according to the thermodynamic 
cluster model. a = 3, b = 0.5, c = 0.2, r = 2.0, MCeq = 1.1, cTh = 0.2, aTh = 10.0, MCTh,eq = MBeq = 1.0 and 
CTh,eq = 0.2. The enantiomeric excesses of the individual contributions are presented and the total 
experimental reverse solution enantiomeric excess eel according to Eq. (5). 
 
7.4 Discussion 
Figure 7.6 shows that a significant reverse enantiomeric excess for the experimental solution 
sample eel can evolve under the chosen conditions as result of the thermodynamic clusters 
according to Eq. (5). The enantiomeric excess of the monomers in the solution eeM, according 
to Eq. (4) returns to zero in the final steady state situation. The final steady state situation of 
the process is depicted in Figure 7.7. M+ and M- are equal, but CTh+ and CTh- are not. Compared 
with the thermodynamic clusters, which are only interacting with M-, the ‘+’ thermodynamic 
clusters experience the extra process of incorporation in the big crystals, leading to a lower 
value of CTh+. The larger value of CTh- thus leads to the persistent reverse ee of the solution 
under grinding conditions. 
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Figure 7.7. Final situation of a Viedma ripening experiment with one enantiomer left in the solid phase according 
to the thermodynamic cluster model.  
 
7.4.1 Estimation of cluster sizes 
To get an impression of the equilibrium number of molecules in the clusters CTh,eq we can 
make an estimation based on classical nucleation theory.8 For the equilibrium concentration 
C(n) of clusters consisting of n>1 molecules in an equilibrium situation the Boltzmann 
distribution at temperature T results in 
,
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where k is the Boltzmann constant and C1 is the concentration of solute monomers in the 
solution. The work W(n) needed for the creation of a cluster of size n is only determined by 
the surface energy of the cluster when we assume the structure of the cluster to be that of 
an infinitely sized crystal as in that case the chemical potential of the molecules in the bulk of 
the cluster µs is equal to that of the monomers in solution µl.  
Neglecting the crudeness of this assumption for small clusters we can determine the work as 
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assuming only spherical clusters with isotropic specific surface energy σ and a molecular 
volume v0. In terms of the variables used in the extended model eq.(6) implies 
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A steady state for the solution reverse enantiomeric excess, eel, in Figure 7.6, is typically 
found for a value of CTh/M ≈ 0.1. Setting eq.(8) equal to this value and solving it for the 
temperature of the experiment (T = 340 K) we find a value for the surface energy, which 
already saturates at a cluster size of n=20 molecules (see Figure 7.8), of 
J.102.2 213/20
  vE  (9) 
The unit cell volume for the case of alanine-4-chlorobenzenesulfonic acid, containing Z=4 
molecules, is V = 1.217 nm3, resulting in a molecular volume v0 = 0.30 nm3, and implying a 
specific surface energy σ = 4.5 mJ/m2. 
 
 
 
 
 
 
 
 
 
 
Figure 7.8. Surface energy Eσ needed for an experimental reverse solution enantiomeric excess, eel, leading to a 
value C/M =0.1 in the thermodynamic cluster model, versus the maximal cluster size included in eq.(8), 
for T = 340 K. 
This value for σ, given the solubility of the amino acid salt of 230-260 mg/mL in pure acetic 
acid, can be compared with the relation between the specific surface energy and the solubility 
proposed by Mersmann, based on thermodynamics and tested for aqueous solutions of various 
salts9  
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where cS and cL are the equilibrium concentration in, respectively, the solid and the solution. 
Eq.(10) is equally well applicable in the case of pure acetic acid as a solvent. Using the known 
values in eq. (10), the specific surface energy is estimated to be σ = 7.8 mJ/m2, which is of 
the same order as the threshold value of 4.5 mJ/m2 found based on our thermodynamic cluster 
model.  
The sizes of the thermodynamic clusters are so small that they will all be collected in a filtered 
sample of the solution. On the other hand, they contain enough molecules as compared to 
the equilibrium solubility to explain the observed reverse enantiomeric excess. The relatively 
low surface energy Eσ needed for the build-up of a non-zero steady state solution reverse 
enantiomeric excess is achieved in the amino acid salt by a relatively low value of the specific 
surface energy, despite the large molecular volume. 
 
7.4.2 Steady state solution 
The set of equations (1) is too complex to solve analytically, even for the steady state 
condition. Starting from the parameter values leading to the results in Figure 7.6, the 
racemization rate in solution r turns out to have only an effect on the total deracemization 
time and no appreciable effect on the steady state values of B+/-, C+/- and CTh+/- , leading to 
a steady state enantiomeric excess for eel as presented in Figure 7.9. 
 
 
 
 
 
 
 
 
 
Figure 7.9. Evolution of the total experimental solution enantiomeric excess, eel, in the deracemization process 
based on the thermodynamic cluster model for a range of racemization rates r = 10.0, 9.0,…., 1.0; 
further paramters: a =3, b = 0.5, c = 0.2, MBeq = 1.0 and MCeq = 1.1, , cTh = 0.2, aTh = 10, MCTh,eq = MBeq 
and C Th,eq= 0.2.   
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7.5 Conclusion 
During Viedma ripening experiments on alanine 4-chlorobenzenesulfonic acid, the solution 
shows a small enantiomeric excess eel with the reverse sign as compared to the solid state 
enantiomeric excess. This reverse solution ee is persistent as long the grinding is maintained. 
A model that includes thermodynamic chiral clusters and their incorporation into larger crystals 
of the same chirality can explain this behavior. The size of the reverse eel is in good agreement 
with the estimated subcritical cluster distribution calculated on the basis of a Boltzmann 
distribution and classical nucleation theory. 
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Deracemization experiment with initial enantiomeric imbalance 
For the experiments (RS)-glutamic acid monohydrate was used combined with (S)-
glutamic acid or (R)-glutamic acid in varying proportions to obtain the desired initial ee (all 
compounds purchased from Sigma-Aldrich (RS)-Glu 98 %; (S)-Glu 99 %; (R)-Glu 99 % ). 
To a 10 mL round bottom flask  with an oval PTFE-coated magnetic stirring bar (L 20 mm, Ø 
10 mm) were added 270-300 mg glutamic acid,  1.7 g glass beads (Ø ca. 2 mm VWR 
international) and 5 mL acetic acid. The flask was equipped with a cooler, stirred at 260 rpm 
and heated up to 70 °C for at least 30 minutes. From this suspension the t = 0 sample was 
taken. The deracemization experiment was started by adding 70 mg salicylaldehyde and 
increasing the temperature  to 90 °C. Solid samples were taken regularly. The chiral purity 
was measured using two different chiral HPLC methods described below. Experiments that 
were conducted at temperatures other than 90 °C were kept all the time at the stated 
temperature.  
Sampling 
For sampling, 1 mL of the slurry was taken with a pipette and vacuum filtered as fast as 
possible at room temperature on a P4 glass filter (Ø 10 mm). The residue was washed with 2 
mL of acetone and dried. 
 
Determination of the ee of the solid samples by chiral HPLC analysis 
Method 1: 
Sample preparation: 1 mg solid in 1 mL Milli Q water, injection volume 10 μL, HPLC 
column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent methanol/water/formic acid 
80/20/0.02 v/v/v, flow 1 mL/min, detection λ=205 nm. Retention times (S)-Glu 5.7 min, (R)-
Glu 8.3 min. Possible side product pyroglutamic acid 4.2 min. Response factor of pyroglutamic 
acid is 15 times higher than of glutamic acid at 205 nm.  
Method 2: 
Sample preparation 1 mg solid in 1 mL Milli Q water, injection volume 4 µL, HPLC column 
Sumichiral OA-5000 (Chrompack) (150x4.6 mm), 5 µm, Varian; eluent 2 mM Cu2SO4 in 
water/isopropanol  98/2 v/v, flow 1 mL/min; post-column derivatization reagent ortho-
phthalaldehyde (OPA) flow 0.8 mL/min; detection 350 nm/450 nm.   
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X-ray diffraction analysis of the formation of the anhydrous conglomerate and 
racemic compound 
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Figure S 1.Sequential development of the crystal structure of glutamic acid under grinding conditions  
(a-e)  a: starting material (RS)-Glutamic acid . 1 H2O (racemic compound), b: a after 1.5 h in acetic 
acid under grinding conditions at room temperature, c: b + 1.5 h at 85 °C under grinding conditions 
(anhydrous racemic conglomerate) d: c + 22 h at 85 °C under grinding conditions, e: d + 21 h under 
grinding conditions (anhydrous racemic compound), f: pure enantiomer (reference). 
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DSC analysis of the melting behavior of the various glutamic acid crystal 
structures 
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Figure S 2. DSC heating traces showing the melting points of the different glutamic acid structures. 
(S)-Glu (anhydrous) and the (RS)-Glu hydrate were purchased from Sigma-Aldrich.  
(RS)-Glu anhydrous conglomerate was produced by recrystallisation of (RS)-Glu hydrate from 
1 N HCl solution.  
(RS)-Glu anhydrous racemic compound was produced by grinding the hydrate in water at 
85 °C. 
Table S 1. Overview over the DSC results of glutamic acid. 
 Onset ( °C) Enthalpy of 
melting (Jg-1) 
(S)-Glutamic acid 192.5 -622 
(RS)-Glutamic acid 
anhydrous 
190.1 -585 
(RS)-Glutamic acid 
hydrate 
178.2 -558  
(RS)-Glutamic acid 
conglomerate 
171.6 -605 
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Yield experiments 
Experiment 1:  
261.49 mg glutamic acid (with an ee of 24 %) used in 5 mL acetic acid with 2.008 g 
glass beads and 70 mg of salicylaldehyde at 70 °C with 300 rpm for 71 h. The yield was 214.6 
mg solid (82.06 %). The solid state contained 0.22 % pyroglutamic acid, 79.027 % (S)-
glutamic acid and 20.748 % (R)-glutamic acid. In solution were 25.04 mg pyroglutamic acid, 
10.4 mg (S)-glutamic acid and 7.49 mg (R)-glutamic acid.  
Experiment 2:  
257.0 mg glutamic acid (with an ee of 24 %) used in 5 mL acetic acid with 2.09 g glass 
beads and 70 mg of salicylaldehyde at 80 °C with 300 rpm for 40 h. The yield was 207.1 mg 
solid (80.58 %). The solid state contained 0.157 % pyroglutamic acid, 93.908 % (S)-glutamic 
acid and 5.9334 % (R)-glutamic acid. In solution were 32.587 mg pyroglutamic acid, 13.118 
mg (S)-glutamic acid and 12.072 mg (R)-glutamic acid.  
The absolute amount of glutamic acid and pyroglutamic acid in the solution were 
determined using HPLC. 
  
Supporting information Chapter 2 
81 
Effect of pyroglutamic acid on the deracemisation rate 
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Figure S 3. Comparison of two grinding experiments with and without additional pyroglutamic acid. 
 
Experiment 1 (without additional pyroglutamic acid): 
211.3 mg RS-Glu . 1 H2O and 78.0 mg S-Glu were added to a 10 mL round bottom flask 
with 2.048 g glass beads and 5 mL acetic acid. The mixture was stirred at 70 °C and with 350 
rpm. The reaction was started by adding salicylaldehyde (70 mg). Several samples were taken 
and analyzed by HPLC.  
Experiment 2 (with additional pyroglutamic acid): 
212.1 mg RS-Glu . 1 H2O and 78.8 mg S-Glu were added to a 10 mL round bottom flask 
with 2.08 g glass beads and 5 mL acetic acid. The mixture was stirred at 70 °C and with 350 
rpm. 44 mg pyroglutamic acid were added and then the reaction was started by adding 
salicylaldehyde (70 mg). Several samples were taken and analyzed by HPLC.  
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Relative stability of the different glutamic acid crystal structures at room 
temperature 
 
Experiment 1: 
5 mL water was saturated with glutamic acid anhydrous racemic compound. The same 
amount of anhydrous racemic compound and glutamic acid hydrate were added. It was stirred 
at 280 rpm using an oval magnetic stirring bar. A first sample was taken immediately and a 
second one after two days. The XRPD showed pure anhydrous racemic compound.  
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Figure S 4. Stability of the two different racemic compounds of glutamic acid at room temperature in water. 
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Experiment 2: 
5 mL acetic acid was saturated with glutamic acid anhydrous racemic compound. The 
same amount of anhydrous racemic compound and glutamic acid conglomerate were added. 
It was stirred with 280 rpm using an oval magnetic stirring bar. A first sample was taken 
immediately and additional ones after two, five, eight and thirty days. Even after eight days 
the XRPD showed a mixture of the two different structures. After thirty days of stirring it was 
apparent that the racemic compound is the more stable one. But there were still some traces 
of the conglomerate structure left. 
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Figure S 5. Stability of the anhydrous racemic compound and the conglomerate at room temperature in acetic 
acid.  
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Experiment 3: 
5 mL acetic acid at 40 °C was saturated with glutamic acid anhydrous racemic 
compound. The same amount of anhydrous racemic compound and glutamic acid 
conglomerate were added. It was stirred with 280 rpm using an oval magnetic stirring bar. A 
first sample was taken immediately and a further ones after four and fourteen days. After four 
days the XRPD showed a mixture of the two different structures. After fourteen days of stirring 
it is apparent that the racemic compound is the more stable one.  
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Figure S 6. Stability of the anhydrous racemic compound and the conglomerate at 40 °C in acetic acid. 
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Deracemisation experiment 
An Ala-CBS deracemisation experiment was typically conducted with (RS)-Ala, a 
variable amount of (R)- or (S)-Ala (in total circa 540 mg) and circa 1.06 g 4-
chlorobenzenesulfonic acid, corresponding to 90 % of the molar amounts of alanine, are 
necessary. These amounts should result in a 10 % excess of free alanine. Due to the lesser 
purity of 4-chlorobenzenesulfonic acid and its hygroscopicity the excess will be somewhat 
higher (about 17 %). To produce the conglomerate these compounds were stirred in 4 mL 
acetic acid in a 10 mL round bottom flask with an oval PTFE-coated magnetic stir bar (L 
20 mm, Ø 10 mm) in the presence of ca. 3 g glass beads (Ø ca. 2 mm VWR international) at 
70 °C. The racemisation reaction was started by adding 70 mg of salicylaldehyde. Samples 
were taken over time. The chemicals were purchased from Sigma Aldrich ((RS)-Ala (99 %), 
(S)-Ala (98 %), (R)-Ala (98 %), 4-chlorobenzenesulfonic acid (90 %) and salicylaldehyde 
(98 %)), except glacial acetic acid which comes from J.T. Baker (99-100 %). 
The Phe-XSA deracemisation experiments were typically conducted with a total amount 
of phenylalanine of around 645 mg with varying amounts of enantiomerically pure substance, 
depending on the chosen ee, and 600 mg of 2,5-xylenesulfonic acid. To produce the 
conglomerate these compounds were stirred in 9 mL acetic acid in a 10 mL round bottom 
flask with an oval PTFE-coated magnetic stir bar (L 20 mm, Ø 10 mm) in the presence of ca. 
2.6 g glass beads (Ø ca. 2 mm VWR international) at 70 °C. The racemisation reaction was 
started by adding 70 mg of salicylaldehyde. Samples were taken over time. The chemicals 
were purchased from Sigma Aldrich ((RS)-Phe (99 %) and (R)-Phe (98 %)), Merck ((S)-Phe 
(99 %)) and Alfa Aesar (2,5-xylenesulfonic acid (99%)). 
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Sampling 
For sampling, including the initial sample, 0.5 mL of the slurry was removed with a 
pipette and vacuum filtered as fast as possible at room temperature on a P4 glass filter (Ø 
10 mm). The residue was washed with 2 mL of acetone to remove the adhering racemic 
solution and dried. 
Determination of the ee of the solid samples by chiral HPLC analysis 
Ala-CBS sample preparation: 3 mg solid in 1 mL Milli Q water, injection volume 10 μL, 
HPLC column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent acetonitrile/water 70/30 
v/v, flow 1 mL/min, detection λ=205 nm. Retention times (S)-Ala-CBS 11.1 min, (R)-Ala-
CBS 12.3 min.  
Phe-XSA sample preparation: 1 mg solid in 1 mL Milli Q water injection volume 5 μL, 
HPLC column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent acetonitrile/water 70/30 
v/v, flow 1 mL/min, detection λ=220 nm. Retention times (S)-Phe-XSA 8.3 min, (R)-Phe-
XSA 9.2 min. 
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X-ray powder diffraction 
 
(S)-Ser-TS and (RS)-Ser-TS were prepared in the same manner. Equimolar amounts 
of serine and p-toluenesulfonic acid were suspended and ground in acetic acid in the presence 
of glass beads for 1.5 h. A sample was filtrated, washed and dried. XRPD patterns were 
recorded (Figure S7). The (S)-Ser-TS XRPD is in good agreement with the single crystal 
structure from the CSD (KERMID). (RS)-Ser-TS shows a different diffractogram, which implies 
that it forms a racemic compound under these conditions.  
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Figure S 7. XRPD patterns of enantiopure and racemic serine p-toluenesulfonate in comparison with the calculated 
XRPD from the CSD structure of (S)-serine toluenesulfonate. 
 
(S)-Leu-XSA and (RS)-Leu-XSA were prepared in the same manner. Equimolar 
amounts of leucine and p-toluenesulfonic acid were suspended and ground in acetic acid in 
the presence of glass beads. A sample was filtrated, washed and dried. XRPD patterns were 
recorded (Figure S8). The (S)-Leu-XSA and (RS)-Leu-XSA XRPD are in good agreement with 
the single crystal structure from the CSD (NOFXAH). This means that it forms a racemic 
conglomerate under these conditions.  
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Figure S 8: X-ray powder diffraction patterns of racemic and enantiopure leucine – pxylenesulfonate (Leu-XSA) 
compared to the XRPD calculated from the Cambridge structural database (CSD) structure (refcode 
NOFXAH). This shows that (RS)-Leu-XSA forms a racemic conglomerate.   
 
(S)-Leu-BSA and (RS)-Leu-BSA were prepared in the same manner. Equimolar 
amounts of leucine and benzenesulfonic acid were suspended and ground in acetic acid in the 
presence of glass beads. A sample was filtrated, washed and dried. XRPD patterns were 
recorded (Figure S9). The (S)-Leu-BSA and (RS)-Leu-BSA XRPD are not in agreement with 
the single crystal structure from the CSD (KERMUP) or each other. It forms under these 
conditions not the hydrate that is found in the CSD but a different, probably water free 
structure, which seems to be a racemic compound. 
Supporting information Chapter 3 
89 
0 10 20 30 40 50
0
2000
4000
6000
8000
10000
12000
14000
16000
in
te
n
s
it
y
2
 (S)-Leu-BSA
 (RS)-Leu-BSA
 KERMUP
 
Figure S 9.  X-ray powder diffraction patterns of racemic and enantiopure leucine – benzenesulfonate (Leu-BSA) 
compared to the XRPD calculated from the Cambridge structural database (CSD) structure (refcode 
KERMUP). This implies that (RS)-Leu-BSA forms a racemic compound and a different structure than 
found in the CSD which is a hydrate. 
 
Yield experiments of alanine 4-chlorobenzenesulfonate 
 
First, the maximum possible yield was determined. Therefore, a grinding experiment 
was started without catalyst. 539 mg (RS)-Ala, 15 mg (R)-Ala and 1070 mg 4-
chlorobenzenesulfonic acid were stirred with 360 rpm at 70 °C with glass beads and 
terminated after 4 h. The solid phase of this experiment was obtained quantitatively. It was 
39 % of the total amount. Then two yield experiments were conducted.  
In the first experiment 530 mg (RS)-Ala, 16 mg (R)-Ala and 1063 mg 4-
chlorobenzenesulfonic acid were stirred in 4 mL acetic acid in the presence of 3.01 g (2 mm) 
glass beads with an oval magnetic stir bar at 70 °C for 2.22 h with 360 rpm. Then the 
racemisation reaction was started by adding 5 drops of salicylaldehyde. The experiment was 
stopped too early namely after 143 hours which resulted in an enantiomeric excess of 72 % 
and a yield of 35 %. 
In the second experiment 532.08 mg (RS)-Ala, 14.93 mg (R)-Ala and 1069.42 mg 4-
chlorobenzenesulfonic acid were stirred in 4 mL acetic acid in the presence of 3.029 g (2 mm) 
glass beads with an oval magnetic stir bar at 70 °C for 1.28 h with 350 rpm. Then the 
racemisation reaction was started by adding 5 drops of salicylaldehyde. The experiment was 
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stopped after 240 hours and the yield (42 %) and enantiomeric excess (100 %) were 
determined.  
These experiments show that the yield of the obtainable solid phase is almost 100 %. 
The only loss is due to the solubility. No side products were detected in HPLC and NMR 
measurements. 
 
Yield experiments of phenylalanine 2,5-xylenesulfonate 
 
Also in this case the maximum possible yield was determined. Therefore, a grinding 
experiment was started without catalyst. 461.9 mg (RS)-Phe, 113.2 mg (S)-Phe and 520.9 
mg 2,5-xylenesulfonic acid were stirred with 300 rpm at 70 °C with glass beads and terminated 
after 4.3 h. The solid phase of this experiment was obtained quantitatively. It was 57 % of 
the total amount. Then, two yield experiments were conducted.  
In the first experiment 440.7 mg (RS)-Phe, 123.3 mg (S)-Phe and 574.8 mg 2,5-
xylenesulfonic acid were stirred in 9 mL acetic acid in the presence of 2.34 g (2 mm) glass 
beads with an oval magnetic stir bar at 70 °C with 300 rpm. Then the racemisation reaction 
was started by adding 4 drops of salicylaldehyde. The experiment was stopped after 504 hours 
which resulted in an enantiomeric excess of 100 % and a yield of 62.8 %. 
In the second experiment 451.9 mg (RS)-Phe, 124.82 mg (S)-Phe and 569.2 mg 2,5-
xylenesulfonic acid were stirred in 9 mL acetic acid in the presence of 2.48 g (2 mm) glass 
beads with an oval magnetic stir bar at 70 °C with 300 rpm. Then the racemisation reaction 
was started by adding 4 drops of salicylaldehyde. The experiment was stopped after 476 hours 
and the yield (59.7 %) and enantiomeric excess (100 %) were determined.  
These experiments show that the yield of the obtainable solid phase is around 100 %. 
The only loss is due to the solubility. No side products were detected in HPLC and NMR 
measurements.  
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HPLC analysis of single crystals 
Several crystals of Ala–CBS, grown from a racemic solution were selected under the 
polarization microscope and subsequently analyzed using chiral HPLC according to the 
procedure described in the experimental section of the main text. The pictures (Figure S10) 
show the crystal and the corresponding enantiomeric excess (ee) in percent (%). The fact 
that isolated crystals exhibit different ee-values supports the fact that these are epitaxial 
conglomerates.  
 
 
 
Figure S 10. Single crystals of Ala-CBS under the polarization microscope and the according enantiomeric 
excess (ee).  
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Occasional instability of the enantiopure end state 
 
Some experiments for Ala-CBS showed a decrease in the solid phase ee after having 
reached 100 % (Figure S11). All XRPD’s of the solid used in these experiments (e.g. Figure 
S11, yellow curve; ee = 26 %) did not show a significant difference between the start (t = 0 h) 
and when the solid phase initial ee was decreasing (t = 147 h) (Figure S11). There is also a 
good agreement with the calculated XRPD of the single crystal X-ray structure (Figure S 12). 
It therefore seems unlikely that the solid transformed into a racemic compound during the 
experiment. The ability to grow epitaxially is a possible explanation for this effect. The 
occurrence of this phenomenon is not completely understood and subject of further research, 
although it seems to be avoidable by scaling up the experiment by a factor of 2. (see Figure 
S 13)  
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Figure S 11. Evolution of the solid phase ee for Ala-CBS with different initial ee values and estimated amounts of 
free alanine as shown. All experiments were conducted at 70 °C under the same conditions as in the 
experimental section. Lines are a guide to the eye. 
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Figure S 12.  XRPDs of the initial-ee = 26 % experiment (yellow curve in Figure S 3). The calculated reference is 
based on the single crystal structure (refcode KERMOJ) from the Cambridge Structural Database 
(CSD). 
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Figure S 13.  Evolution of the solid phase ee for Ala-CBS starting from different initial ee values and estimated 
amounts of free alanine as shown. All experiments were conducted at 70 °C with twice the amount 
of salt, solvent, catalyst and glass beads as compared to the values mentioned in the experimental 
section. Lines are a guide to the eye.  
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Racemisation of Alanine 4-chlorobenzenesulfonate and Phenylalanine 2,5-
xylenesulfonic acid 
Racemisation is a very important part of Viedma ripening and must occur within a 
reasonable time. In the case of the amino acid sulfonates the formation of the Schiff base is 
hampered by the protonated aminogroup. As a consequence, decelerated or no racemisation 
at all is observed as in the racemisation experiment with 3 % free alanine (Figure S14). When 
working with amino acid sulfonates the racemisation speed does not only depend on the 
amount of catalyst but also on the amount of free amino acid. The ideal amount of free amino 
acid should be determined individually for different amino acid sulfonates. In the case of 
phenylalanine it makes less difference how much free amino acid was used (Figure S15). All 
experiments were conducted in the absence of solids (for details see Table S2 and S3).  
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Figure S 14. Evolution of the solution ee for Ala-CBS starting from different initial estimated amounts of free alanine 
as shown. All experiments were conducted at 70 °C. Lines are a guide to the eye.  
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Table S 2. Experimental details of the racemisation experiments. All experiments were conducted with 10 mL of 
acetic acid and 45 mg of salicylaldehyde. The varying amounts of alanine and 4-
chlorobenzenesulfonic acid and the subsequent amount of free alanine are given below. 
experiment amount of Ala [mg] amount of CBS [mg] amount of free Ala [%] 
1 55.70 127.50 2.8 
2 52.96 106.14 14.9 
3 46.99 93.31 15.6 
4 47.46 84.28 24.6 
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Figure S 15. Evolution of the solution ee for Phe-XSA starting from different initial estimated amounts of free 
phenylalanine as shown. All experiments were conducted at 70 °C. Lines are a guide to the eye. 
 
Table S 3. Experimental details of the racemisation experiments. All experiments were conducted with 20 mL of 
acetic acid and 45 mg of salicylaldehyde. The varying amounts of phenylalanin and 2,5-xylenesulfonic 
acid and the subsequent amount of free phenylalanine are given below. 
experiment amount of Phe [mg] 
amount of XSA 
[mg] 
amount of free Phe 
[%] 
1 55.05 61.74 0.5 
2 50.37 50.48 11.1 
3 58.09 51.96 20.7 
4 55.84 42.08 33.2 
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Deracemisation experiment 
A deracemisation experiment was typically conducted with 1.47 g N-Acetyl-DL-
Leucine and 0.2 g N-Acetyl-L-Leucine. The conglomerate was stirred in 4.5 mL acetic acid 
in a 10 mL round bottom flask with an oval PTFE-coated magnetic stirring bar (L 20 mm, Ø 
10 mm) in the presence of ca. 3.3 g glass beads (Ø ca. 2 mm VWR international) at 40 °C. 
The racemisation reaction was started by adding 0.5 mL of acetic anhydride. Samples were 
taken over time. The chemicals were purchased from Alfa Aesar (N-Acetyl-DL-Leucine 
(99 %)) and Sigma-Aldrich (N-Acetyl-L-Leucine (99 %) and acetic anhydride). 
 
Sampling 
For sampling, including the initial sample, 0.5 mL of the slurry was removed with a 
pipette and vacuum filtered as fast as possible at room temperature on a P4 glass filter (Ø 
10 mm). The residue was washed with 2 mL of cold water to remove the adhering racemic 
solution and dried. 
 
Determination of the ee of the solid samples by chiral HPLC analysis  
Method 1: 
Sample preparation: 1 mg solid in 1 mL isopropanol, injection volume 10 μL, HPLC 
column AD-H (250x4.6 mm ID); eluent heptane/isopropanol 90/10 v/v, flow 1 mL/min, 
detection λ=205 nm. Retention times N-Acetyl-D-Leucine 7.8 min, N-Acetyl-L-Leucine 
9.6 min.  
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Method 2: 
Sample preparation: 1 mg solid in 1 mL Milli Q water, injection volume 10 μL, HPLC 
column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent methanol/water/formic acid 
80/20/0.02 v/v/v, flow 1 mL/min, detection λ=205 nm. Retention times N-Acetyl-L-Leucine 
3.3 min, N-Acetyl-D-Leucine 4.0 min.  
NMR data for N-Acetyl-Leucine 
 
1H-NMR experiments were recorded on a 300 MHz spectrometer. Chemical shifts (δ) are 
quoted in parts per million (ppm) and calibrated by setting the solvent (DMSO-d6) residual 
peak to 2.5 ppm for the 1H-NMR experiments. 
 
Solid phase 
1H NMR (300 MHz, DMSO-d6, 25°C): δ = 0.82-0.84 (d, 3H), 0.87-0.89 (d, 3H), 1.43 (m, 
2H), 1.53-1.69 (sept, 1H), 1.83 (s, 3 H), 4.15-4.22 (q, 1H), 8.05-8.08 (d, 1H), 12.45 (bs, 1H) 
 
Compound recovered from the solution after grinding 
 
1H NMR (300 MHz, DMSO-d6, 25°C): δ = 0.82-0.84 (d, 3H), 0.87-0.89 (d, 3H), 1.43 (m, 2H), 
1.53-1.69 (sept, 1H), 1.83 (s, 3 H), 4.15-4.22 (q, 1H), 8.05-8.08 (d, 1H) 
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Deracemisation experiment 
An Ala-CBS deracemisation experiment was typically conducted with (RS)-Ala (1.4 g), 
(R)- or (S)-Ala (0.12 g) and circa 3 g 4-chlorobenzenesulfonic acid, corresponding to 90 % of 
the molar amounts of alanine, are necessary. These amounts should result in a 10 % excess 
of free alanine. Due to the lesser purity of 4-chlorobenzenesulfonic acid and its hygroscopicity 
the excess will be somewhat higher (about 17 %). To produce the conglomerate these 
compounds were stirred in 10 mL acetic acid in a 25 mL round bottom flask with an oval PTFE-
coated magnetic stir bar (L 20 mm, Ø 10 mm) in the presence of ca. 7.5 g glass beads (Ø ca. 
2 mm VWR international) at 70 °C. The racemisation reaction was started by adding 200 mg 
of salicylaldehyde. Samples were taken over time. The chemicals were purchased from Sigma 
Aldrich ((RS)-Ala (99 %), (S)-Ala (98 %), (R)-Ala (98 %), 4-chlorobenzenesulfonic acid 
(90 %) and salicylaldehyde (98 %)), except glacial acetic acid which comes from J.T. Baker 
(99-100 %). 
 
Sampling 
For sampling, including the initial sample, 0.5 mL of the slurry was removed with a 
pipette and vacuum filtered as fast as possible at room temperature on a P4 glass filter (Ø 
10 mm). The residue was washed with 2 mL of acetone to remove the adhering racemic 
solution and dried.  
The sample for the determination of the solution ee was received during the filtration 
process by collecting the filtrate and the acetone. The liquids were evaporated and the 
resulting crystals dried. 
The second method used was by extracting it directly from the round bottom flask with 
a 1 mL syringe equipped with a poroplast cannula filter (10, 4 or 1 micron) (Quality Lab 
Accessories). The solution was immediately transferred into a small vial. Acetone was added 
to the solution to reduce the temperature rapidly and terminate thereby the racemisation 
reaction. Crystallization occurred instantaneously after adding the anti solvent acetone.  
Supporting information Chapter 7 
99 
 
Figure S 16. Picture of the device used in the second method. A syringe equipped with a poroplast cannula filter.  
 
Determination of the ee of the solid samples by chiral HPLC analysis  
Ala-CBS sample preparation: 3 mg solid in 1 mL Milli Q water, injection volume 10 μL, 
HPLC column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent acetonitrile/water 70/30 
v/v, flow 1 mL/min, detection λ=205 nm. Retention times (S)-Ala-CBS 11.1 min, (R)-Ala-
CBS 12.3 min.  
Phe-XSA sample preparation: 1 mg solid in 1 mL Milli Q water injection volume 5 μL, 
HPLC column Chirobiotic T (250x4.6 mm ID), 5 µm, Astec; eluent acetonitrile/water 70/30 
v/v, flow 1 mL/min, detection λ=220 nm. Retention times (S)-Phe-XSA 8.3 min, (R)-Phe-
XSA 9.2 min.
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Summary 
 
Chiral purification of organic compounds is of paramount importance in the 
pharmaceutical industry but also in the food and agricultural industry. The homochirality of 
Nature leads to chiral recognition and the human body can distinguish between different 
enantiomers of chiral molecules. The consequence is sometimes a difference in taste or smell, 
but in the most extreme cases it can imply the difference between death and cure.  
A chemical synthesis often results in a racemate that must be purified afterwards. One 
of the latest inventions for chiral purification is Viedma ripening. For that a racemic or scalemic 
mixture of conglomerate crystals is ground in contact with its saturated solution. In the 
solution a racemization reaction needs to be active. The solid phase in such a process evolves 
over time to an enantiomerically pure end state. Therefore Viedma ripening is a 
deracemization method rather than a resolution.  
Viedma ripening requires that the compound crystallizes as a racemic conglomerate, 
meaning that each crystal contains either (S) or (R) molecules. Unfortunately only around 
10 % of all chiral organic compounds crystallize in this manner. The more abundant crystal 
structure is a racemic compound where both enantiomers are part of the unit cell. Molecules 
that crystallize in this way cannot be deracemized using Viedma ripening. The goal of the 
research in this thesis was to find ways for also enantiomerically purifying such racemic 
compounds. 
The first example is the complete deracemization of the proteinogenic amino acid 
glutamic acid (chapter 2). In the literature this compound is claimed to form a racemic 
conglomerate, but the most stable crystal structure turns out to be that of a racemic 
compound. We developed a method by exploiting Ostwald’s rule of stages and made use of a 
metastable conglomerate crystal structure. Complete deracemization was possible by carefully 
tuning the experimental conditions before the conversion into the racemic compound 
occurred.  
In the second example two racemic compound forming amino acids, alanine and 
phenylalanine are studied (chapter 3). Both compounds can be transformed into stable 
racemic conglomerates by screening for an appropriate salt. Benzene sulfonic acid salts 
enabled a complete deracemization of both amino acids.  
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As alternative to the grinding method of Viedma ripening, a temperature cycling 
approach was recently employed, by Coquerel et al.. Chapter 4 studies the applicability of this 
method for the two amino acid salts. The major question was whether the deracemization 
would be faster using temperature cycling and what effect the various experimental conditions 
have on the deracemization rate. The deracemization of the amino acid salts using 
temperature cycling was indeed faster.  
Asparagine is one of the two proteinogenic amino acids that forms a racemic 
conglomerate and thus appears suitable for normal Viedma ripening. The crystal structure, 
however, is not stable under the racemization conditions for amino acids and a different route 
is needed. Purification of this compound can be conducted by coupling two Viedma ripening 
setups with small initial enantiomeric excess in the L and D enantiomer respectively and 
without racemization in the solution (chapter 5). The solution is exchanged, crystal free, 
between the two vessels and the solid phase of the slurry evolved to 100 % enantiomerical 
purity. In the end one vessel contained only the L and the other only the D enantiomer. 
Another possibility of converting a racemic compound into a racemic conglomerate is 
derivatization. N-Acetyl-leucine is a derivative of the proteinogenic amino acid leucine. 
Although it forms a stable conglomerate and is racemizable, the deracemization of this 
compound did not proceed as expected (chapter 6). It is a good example to show the 
importance of determining the yield during the development of a new Viedma ripening 
application. 
During the deracemization experiments with the amino acids salts a persistent reverse 
enantiomeric excess in the solution was found that is unexpected based on existing models 
for Viedma ripening. Chapter 7 therefore presents an extended model that involves 
thermodynamical clusters and indeed explains this phenomenon. 
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Samenvatting 
Chirale zuivering is belangrijk bij het produceren van medicijnen maar ook in de voedsel- 
en landbouwindustrie. De homochiraliteit in levende organismen is verantwoordelijk voor 
chirale onderscheiding. Het menselijk lichaam is in staat om de chirale vormen van moleculen, 
de enantiomeren, te herkennen. Dit uit zich in een verschil in smaak of geur, maar kan ook 
het verschil uitmaken tussen dood en genezing.  
Een chemische synthese eindigt meestal in een racemisch mengsel dat achteraf 
gezuiverd moet worden. Viedma ripening is een van de meest recente uitvindingen op het 
gebied van chirale zuivering. Hierbij wordt een (bijna) racemisch mengsel van conglomeraat 
kristallen vermalen in contact met een verzadigde oplossing. In deze verzadigde oplossing 
vindt een racemisatiereactie plaats. In de loop van de tijd wordt bij dit proces de gehele vaste 
fase enantiomeer zuiver. Viedma ripening is dus eerder een deracemisatie- dan een 
resolutieproces.  
Voor Viedma ripening is het essentieel dat de kristallijne fase een conglomeraat is, 
hetgeen betekent dat de kristallen uit puur (R) of (S) moleculen zijn opgebouwd. Slechts 10 
% van de chirale organische verbindingen vormt een conglomeraat. De meest voorkomende 
kristalstructuur is een racemaat, waarvoor beide enantiomeren aanwezig zijn in de 
eenheidscel. Als moleculen als racemaat kristalliseren, kunnen ze niet met het behulp van 
Viedma ripening gederacemiseerd worden. Het onderzoeksdoel van dit proefschrift was 
mogelijkheden te vinden om ook racematen enantiomeer zuiver te kunnen maken. 
Het eerste voorbeeld is de volledige deracemisatie van glutaminezuur, dat een 
bestanddeel van eiwitten is (hoofdstuk 2). Volgens de literatuur vormt glutaminezuur een 
conglomeraat, maar het bleek dat de meest stabiele kristalstructuur die van een racemaat is. 
Toch is het gelukt om een methode te ontwikkelen die gebruik maakt van Ostwald’s rule of 
stages waarbij tijdelijk een metastabiel conglomeraat van glutamine zuur wordt gevormd. 
Volledige deracemisatie werd bereikt door de experimentele condities zodanig aan te passen 
dat het glutaminezuur voldoende lang in de metastabiele conglomeraatstructuur bleef.  
Het tweede voorbeeld betreft twee aminozuren die eveneens een racemaat vormen, 
alanine en fenylalanine (hoofdstuk 3). Er is voor deze aminozuren gezocht naar geschikte 
zouten die als conglomeraat kristalliseren. In de familie van benzeensulfonzuurzouten bleken 
geschikte kandidaten te vinden die de volledige deracemisatie van de twee aminozuren 
mogelijk maakten. Recentelijk hebben Coquerel et al. een alternatief voor het malen tijdens 
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Viedma ripening ontwikkeld, in de vorm van een cyclische temperatuurverloop. In hoofdstuk 
4 wordt de toepasbaarheid van een dergelijk temperatuurprogramma voor de aminozuur-
zouten uit hoofdstuk 3 onderzocht. De belangrijkste vraag was of de deracemisatie met behulp 
van een cyclisch temperatuurprogramma eerder zou zijn voltooid dan met het maalproces. 
Ook werd de invloed van andere experimentele condities op de deracemisatiesnelheid 
onderzocht. Deracemisatie met een cyclisch temperatuurprogramma bleek in bepaalde 
gevallen inderdaad sneller dan het maalproces.  
Een van de twee eiwitbouwstenen die een conglomeraat vormen is asparagine. Dit 
aminozuur lijkt daarmee een geschikte kandidaat voor Viedma ripening. De kristalstructuur 
bleek echter niet stabiel te zijn onder de racemisatiecondities voor aminozuren, waardoor een 
andere aanpak nodig was. Men kan chirale zuivering van asparagine ook bereiken zonder 
racemisatie in de oplossing, namelijk door twee vaten, met een klein overschot in 
respectievelijk de L en de D enantiomeer, te koppelen. (hoofdstuk 5). Via die koppeling 
worden de oplossingen uitgewisseld, waarbij de kristallen worden tegengehouden met behulp 
van filters. Met een dergelijke opstelling levert 100 % zuivere enantiomeren in de loop van de 
tijd. Aan het het eind van het proces bevat een vat uitsluitend de L en het andere uitsluitend 
de D enantiomeer in de vaste fase. 
Een andere optie om van een racemisch mengsel een conglomeraat te maken is om de 
verbinding te modificeren. N-acetylleucine is een modificatie van het aminozuur leucine. 
Hoewel N-actylleucine een stabiel conglomeraat vormt en ook te racemiseren is doen zich 
tijdens de deracemisatie problemen voor (hoofdstuk 6). Deze verbinding is een mooi 
voorbeeld om mogelijke problemen tijdens Viedma ripening in beeld te brengen en in het 
bijzonder om het belang te illustreren van de bepaling van de opbrengst tijdens een Viedma 
ripening proces.  
Tijdens de deracemisatie van de aminozuurzouten van hoofdstuk 3 bleek in de oplossing 
een enantiomeeroverschot aanwezig, met een teken tegengesteld aan het overschot in de 
vaste fase. In tegenstelling tot hetgeen bekend was uit bestaande theoretische modellen voor 
Viedma ripening bleef dat inverse enantiomeeroverschot onverminderd aanwezig, zelfs na 
volledige deracemisatie, zolang er werd gemalen. Hoofdstuk 7 beschrijft een uitgebreid model 
dat de aanwezigheid van thermodynamisch stabiele clusters meeneemt en dat dit verschijnsel 
kan verklaren. 
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Zusammenfassung 
 
In der pharmazeutischen Industrie, sowie der Lebensmittel- und Agrarindustrie ist es 
von höchster Bedeutung chirale Stoffe enantiomerenrein herstellen zu können. Die 
Homochiralität in der Natur führt zu chiraler Erkennung. Der menschliche Körper kann 
zwischen verschiedenen Enantiomeren unterscheiden. Dies kann zu einem Unterschied bei 
Geschmack oder Geruch führen, im äußersten Fall kann es der Unterschied zwischen Tod und 
Heilung sein.  
Bei einer chemischen Synthese entsteht meistens ein racemisches Gemisch, welches 
danach in einem weiteren Schritt aufgereinigt werden muss. Viedma ripening ist eine der 
neuesten Entwicklungen für die Herstellung enantiomerenreiner Stoffe. Bei dieser Methode 
werden Kristalle als racemisches Gemisch oder mit leichtem Enantiomerenüberschuss in 
Kontakt mit ihrer gesättigten Lösung gemahlen. Man benötigt eine Racemisierungsreaktion in 
der Lösung. Im Verlaufe der Zeit entwickelt sich die feste Phase von racemisch zu 
enantiomerenrein. Es handelt sich daher eher um eine Deracemisierung als eine 
Racematspaltung.  
Für Viedma ripening braucht man eine Verbindung, die als ein Konglomerat kristallisiert. 
Hierbei beinhalten die Kristalle jeweils nur (R) beziehungsweise (S) Moleküle. Es kristallisieren 
leider nur 10 % aller organischen Verbindungen auf diese Art und Weise. Die deutlich 
häufigere Kristallstruktur ist die racemische Verbindung bei der beide Enantiomeren Teil der 
Einheitszelle sind. Wenn Moleküle auf diese Art kristallisieren können sie nicht durch Viedma 
ripening enantiomerenrein gemacht werden. Das Ziel dieser Doktorarbeit war darum Wege zu 
finden um diese racemischen Verbindungen zugänglich zu machen für Viedma ripening.  
Das erste Beispiel ist die vollständige Deracemisierung von der proteinogenen 
Aminosäure Glutaminsäure (Kapitel 2). Gemäß der Literatur bildet es ein Konglomerat, aber 
unsere Untersuchungen haben bestätigt, dass die stabilste Kristallstruktur eine racemische 
Verbindung ist. Wir haben eine Methode entwickelt, die Ostwalds Stufenregel benutzt und mit 
einer metastabilen Kristallstruktur arbeitet. Die vollständige Deracemisierung wurde 
ermöglicht, bevor die Aminosäure sich in die stabilere Kristallstruktur umgewandelt hatte, 
durch vorsichtiges Anpassen der experimentellen Bedingungen. 
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Im zweiten Beispiel wurden zwei weitere proteinogene Aminosäuren die eine racemische 
Verbindung formen, Alanin und Phenylalanin, untersucht (Kapitel 3). Durch ein 
Auswahlverfahren konnte für beide Aminosäuren ein geeignetes Salz gefunden werden, das 
ein stabiles Konglomerat bildet. Aromatische Sulfonsäuren ermöglichen die vollständige 
Deracemisierung beider Aminosäuren.  
Als Alternative zum Vermahlen der Kristalle während des Viedma ripening Prozesses 
haben Coquerel et al. ein Temperaturprogramm benutzt. In Kapitel 4 wird die Anwendbarkeit 
dieser Variante auf die Aminosäurensalze untersucht. Im Mittelpunkt stand die Frage ob der 
Deracemisierungsprozess schneller verlaufen würde und auch der Einfluss der anderen 
Faktoren auf die Deracemisierungsrate. Die Deracemisierung der Aminosäurensalze war in der 
Tat schneller mit Hilfe des Temperaturprogrammes verglichen mit dem Vermahlen der Kristalle 
beim klassischen Viedma ripening.  
Asparagin ist eine der beiden proteinogenen Aminosäuren, die ein Konglomerat bilden 
und somit geeignet scheint für den Viedma ripening Prozess. Die Kristallstruktur des 
Konglomerats ist jedoch nicht stabil unter den Racemisierungsbedingungen von Aminosäuren 
weshalb eine andere Route gebraucht wird. Die Aufreinigung dieses Stoffes kann erreicht 
werden indem man zwei Viedma ripening Aufstellungen mit einem kleinen 
Enantiomerenüberschuss jeweils in L bzw. D miteinander koppelt, wobei keine Racemisierung 
in der Lösung stattfindet (Kapitel 5). Die Lösung wird, kristallfrei, zwischen den beiden Kolben 
kontinuierlich ausgetauscht wodurch die feste Phase der Suspension sich im Verlaufe der Zeit 
zu 100 % enantiomerenrein entwickelt. Am Ende dieses Prozess befinden sich in dem einen 
Kolben ausschließlich L und in dem anderen ausschließlich D Kristalle.  
Eine weitere Möglichkeit um racemische Verbindungen in ein Konglomerat zu überführen 
ist Derivatisierung. N-Acetyl-Leucin ist ein Derivat der proteinogenen Aminosäure Leucin. 
Obwohl es ein stabiles Konglomerat formt und auch racemisierbar ist, stößt man während der 
Entwicklung eines Deracemisierungsprozesses auf Komplikationen (Kapitel 6). Es ist ein gutes 
Beispiel, welches nachdrücklich zeigt wie wichtig die Bestimmung der Ausbeute ist bei der 
Entwicklung eines neues Viedma ripening Prozesses.  
Während der Deracemisierung der Aminosäurensalze wurde ein nachhaltiger, 
umgekehrter Enantiomerenüberschuss in der Lösung festgestellt der, betrachtet man die 
bestehenden Modellen zu Viedma ripening, unerwartet war. In Kapitel 7 wird ein neues, 
erweitertes Modell vorgestellt welches thermodynamische Cluster beinhaltet und somit in der 
Lage ist dieses Phänomen zu erklären. 
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Kollegin), Regine (Du hast mir gezeigt wie genial Cake Pops sind). Der Herr Fischer (ich freue 
mich darauf mit dir im Altenheim zu sitzen und über alle anderen zu lästern), Karsten (deine 
Filmabende sind die besten). Kerstin (danke für viele Spieleabende und dass du in den 
Limbecker Platz gekommen bist). Nico (Vainstream, Fußball und Frühstücksunterhaltungen), 
Markus (ich kann noch immer dein Lachen hören). 
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Christine, du bist eine wunderschöne und faszinierende Frau. Wir lieben den gleichen 
Dichter (Heinrich Heine) und haben ähnliche Sorgen. Deine Kochkünste sind unübertroffen, 
vor allem wenn es um Frühstück geht.  
Holger, du warst immer für mich da. Mit einem offenen Ohr oder leckerem Essen, 
meistens beides gleichzeitig. Ich bin zutiefst dankbar dafür. Und auch dass ich deinen Mini 
fahren durfte. Außerdem bist du einer der wenigen Menschen, die mein Nederdeutsch 
verstehen.  
Zum Schluss möchte ich meinen Mitbewohner danken. Ihr habt mein Leben bereichert. 
Es ist chaotisch, dreckig, laut und schön geworden durch euch. Ich liebe euch mehr als alles 
andere auf der Welt. Danke dass es euch gibt, Rambo, Buffy und Toffifee aka die Kamikatze.  
